Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyBiologicalProcess	positive regulation of nuclear-transcribed mRNA poly(A) tail shortening	PABPC1 BTG2 PABPC3 CNOT1	1.88e-06	14	139	4	GO:0060213
GeneOntologyBiologicalProcess	regulation of nuclear-transcribed mRNA poly(A) tail shortening	PABPC1 BTG2 PABPC3 CNOT1	3.38e-06	16	139	4	GO:0060211
GeneOntologyCellularComponent	Cul3-RING ubiquitin ligase complex	KLHL25 KLHL13 DEPDC5 KLHL8	1.25e-04	39	138	4	GO:0031463
GeneOntologyCellularComponent	TTT Hsp90 cochaperone complex	TELO2 TTI1	1.29e-04	3	138	2	GO:0110078
GeneOntologyCellularComponent	cytoplasmic stress granule	ATXN2L PABPC1 CELF1 PABPC3 ELAVL1	4.40e-04	96	138	5	GO:0010494
GeneOntologyCellularComponent	mCRD-mediated mRNA stability complex	PABPC1 PABPC3	6.38e-04	6	138	2	GO:0106002
GeneOntologyCellularComponent	eukaryotic translation initiation factor 2 complex	EIF2S3B EIF2S3	6.38e-04	6	138	2	GO:0005850
Domain	DUF4599	SPATA31A3 SPATA31A7 SPATA31A6 SPATA31A5	1.31e-06	12	137	4	PF15371
Domain	DUF4599	SPATA31A3 SPATA31A7 SPATA31A6 SPATA31A5	1.31e-06	12	137	4	IPR027970
Domain	-	MROH5 WDFY4 ARID1B TELO2 INSC ASPM TTI1 PDS5A WDFY3	3.87e-05	222	137	9	1.25.10.10
Domain	ARM-type_fold	DOCK3 INTS1 MROH5 WDFY4 FOCAD TELO2 INSC ASPM TTI1 PDS5A WDFY3	4.14e-05	339	137	11	IPR016024
Domain	Hud_Sxl_RNA	RBMS2 CELF1 ELAVL1	4.46e-05	10	137	3	IPR002343
Domain	SSDP_DNA-bd	SSBP3 SSBP4	1.59e-04	3	137	2	IPR008116
Domain	ARM-like	MROH5 WDFY4 ARID1B TELO2 INSC ASPM TTI1 PDS5A WDFY3	1.73e-04	270	137	9	IPR011989
Domain	PH_dom-like	PSD2 MYO10 ITSN1 AGAP11 PLEKHA6 WDFY4 SPTBN5 SHC2 IRS2 TNS4 WDFY3	3.08e-04	426	137	11	IPR011993
Domain	COE	EBF1 EBF2	3.17e-04	4	137	2	PS01345
Domain	Transcription_factor_COE	EBF1 EBF2	3.17e-04	4	137	2	IPR003523
Domain	COE_HLH	EBF1 EBF2	3.17e-04	4	137	2	IPR032201
Domain	COE_DBD	EBF1 EBF2	3.17e-04	4	137	2	IPR032200
Domain	Transcription_factor_COE_CS	EBF1 EBF2	3.17e-04	4	137	2	IPR018350
Domain	COE1_HLH	EBF1 EBF2	3.17e-04	4	137	2	PF16423
Domain	COE1_DBD	EBF1 EBF2	3.17e-04	4	137	2	PF16422
Domain	BTB	HIC1 KLHL25 BTBD7 KLHL13 KLHL8 ABTB2	4.12e-04	131	137	6	PF00651
Domain	PolyA	PABPC1 PABPC3	5.26e-04	5	137	2	SM00517
Domain	-	PABPC1 PABPC3	5.26e-04	5	137	2	1.10.1900.10
Domain	PABP	PABPC1 PABPC3	5.26e-04	5	137	2	PF00658
Domain	PABP_1234	PABPC1 PABPC3	5.26e-04	5	137	2	IPR006515
Domain	PABC	PABPC1 PABPC3	5.26e-04	5	137	2	PS51309
Domain	PABP_HYD	PABPC1 PABPC3	5.26e-04	5	137	2	IPR002004
Domain	Nucleotide-bd_a/b_plait	RBMS2 MATR3 HNRNPM PABPC1 PARP10 CELF1 PABPC3 ELAVL1	6.42e-04	258	137	8	IPR012677
Domain	BACK	KLHL25 BTBD7 KLHL13 KLHL8	9.83e-04	60	137	4	SM00875
Domain	BACK	KLHL25 BTBD7 KLHL13 KLHL8	1.05e-03	61	137	4	IPR011705
Domain	BACK	KLHL25 BTBD7 KLHL13 KLHL8	1.05e-03	61	137	4	PF07707
Domain	PH_DOMAIN	PSD2 ADRM1 MYO10 ITSN1 AGAP11 PLEKHA6 SPTBN5 IRS2	1.07e-03	279	137	8	PS50003
Domain	RRM	RBMS2 MATR3 HNRNPM PABPC1 CELF1 PABPC3 ELAVL1	1.11e-03	217	137	7	SM00360
Domain	BTB	HIC1 KLHL25 BTBD7 KLHL13 KLHL8 ABTB2	1.18e-03	160	137	6	PS50097
Domain	RRM_dom	RBMS2 MATR3 HNRNPM PABPC1 CELF1 PABPC3 ELAVL1	1.44e-03	227	137	7	IPR000504
Domain	PH-BEACH_dom	WDFY4 WDFY3	1.45e-03	8	137	2	IPR023362
Domain	-	WDFY4 WDFY3	1.45e-03	8	137	2	2.30.29.40
Domain	PH_BEACH	WDFY4 WDFY3	1.45e-03	8	137	2	PS51783
Domain	PH	PSD2 MYO10 ITSN1 AGAP11 PLEKHA6 SPTBN5 IRS2	1.52e-03	229	137	7	PF00169
Domain	RRM	RBMS2 MATR3 HNRNPM PABPC1 CELF1 PABPC3 ELAVL1	1.56e-03	230	137	7	PS50102
Domain	PH_dom-spectrin-type	PSD2 SPTBN5	1.86e-03	9	137	2	IPR001605
Domain	BEACH	WDFY4 WDFY3	1.86e-03	9	137	2	PS50197
Domain	Beach	WDFY4 WDFY3	1.86e-03	9	137	2	PF02138
Domain	-	WDFY4 WDFY3	1.86e-03	9	137	2	1.10.1540.10
Domain	Beach	WDFY4 WDFY3	1.86e-03	9	137	2	SM01026
Domain	BEACH_dom	WDFY4 WDFY3	1.86e-03	9	137	2	IPR000409
Domain	bZIP_1	ATF7 FOS CREM	1.96e-03	34	137	3	PF00170
Domain	BTB	HIC1 KLHL25 BTBD7 KLHL13 KLHL8 ABTB2	2.14e-03	180	137	6	SM00225
Domain	-	RBMS2 MATR3 HNRNPM PABPC1 CELF1 PABPC3 ELAVL1	2.18e-03	244	137	7	3.30.70.330
Domain	-	PSD2 MYO10 ITSN1 AGAP11 PLEKHA6 SPTBN5 SHC2 IRS2 TNS4	2.40e-03	391	137	9	2.30.29.30
Domain	BTB/POZ_dom	HIC1 KLHL25 BTBD7 KLHL13 KLHL8 ABTB2	2.45e-03	185	137	6	IPR000210
Domain	TF_DNA-bd	ATF7 FOS CREM	2.50e-03	37	137	3	IPR008917
Domain	SKP1/BTB/POZ	HIC1 KLHL25 BTBD7 KLHL13 KLHL8 ABTB2	2.73e-03	189	137	6	IPR011333
Domain	Znf_C2H2_matrin	MATR3 ZNF318	3.36e-03	12	137	2	IPR000690
Domain	BTB-kelch_protein	KLHL25 KLHL13 KLHL8	3.85e-03	43	137	3	IPR017096
Domain	IQ_motif_EF-hand-BS	MYO10 MYH7B SCN10A ASPM	4.35e-03	90	137	4	IPR000048
Domain	RRM_1	RBMS2 HNRNPM PABPC1 CELF1 PABPC3 ELAVL1	4.36e-03	208	137	6	PF00076
Domain	PH	PSD2 MYO10 ITSN1 AGAP11 PLEKHA6 SPTBN5 IRS2	4.47e-03	278	137	7	SM00233
Domain	PH_domain	PSD2 MYO10 ITSN1 AGAP11 PLEKHA6 SPTBN5 IRS2	4.65e-03	280	137	7	IPR001849
Domain	IQ	MYO10 MYH7B SCN10A ASPM	4.89e-03	93	137	4	PS50096
Domain	AT_hook	KMT2C DOT1L	5.99e-03	16	137	2	PF02178
Domain	BRLZ	ATF7 FOS CREM	6.56e-03	52	137	3	SM00338
Domain	BZIP_BASIC	ATF7 FOS CREM	6.92e-03	53	137	3	PS00036
Domain	BZIP	ATF7 FOS CREM	6.92e-03	53	137	3	PS50217
Domain	bZIP	ATF7 FOS CREM	7.29e-03	54	137	3	IPR004827
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	TANC2 DOCK3 SEMA6C TFEB MYO10 INTS1 REV3L MED13L ITPR3 FOCAD ZCCHC14 KMT2C KLHL25 PNPLA6 ZNRF3 ADAMTS7 BTBD7 DEPDC5 IRS2 POFUT1 WDFY3 DOT1L SSBP4 ESPL1 TOP3B ABTB2 BAHCC1	5.68e-14	1105	141	27	35748872
Pubmed	The testis-specific VAD1.3/AEP1 interacts with β-actin and syntaxin 1 and directs peri-nuclear/Golgi expression with bipartite nucleus localization (BNL) sequence.	SPATA31A3 SPATA31A7 SPATA31A6 SPATA31A5 SPATA31A1	6.10e-12	6	141	5	20850414
Pubmed	Targeted disruption of the spermatid-specific gene Spata31 causes male infertility.	SPATA31A3 SPATA31A7 SPATA31A6 SPATA31A5 SPATA31A1	6.10e-12	6	141	5	25930072
Pubmed	PRISMA and BioID disclose a motifs-based interactome of the intrinsically disordered transcription factor C/EBPα.	ATF7 ATXN2L NCOA3 NR2C1 CHD7 ZNF318 MED13L PABPC1 ZEB2 CCNT2 KMT2C TAOK3 ARID1B TEX30 CELF1 EIF2S3 ELAVL1 PDS5A MED27 CNOT1	2.28e-08	1103	141	20	34189442
Pubmed	Construction of expression-ready cDNA clones for KIAA genes: manual curation of 330 KIAA cDNA clones.	CHD7 SIK3 MED13L DSCAML1 ZCCHC14 KMT2C ZNRF3 POFUT1 WDFY3 KLHL8	3.10e-08	225	141	10	12168954
Pubmed	Majority of cerebrospinal fluid-contacting neurons in the spinal cord of C57Bl/6N mice is present in ectopic position unlike in other studied experimental mice strains and mammalian species.	SPATA31A3 SPATA31A7 SPATA31A6 SPATA31A5 SPATA31A1	4.07e-08	24	141	5	32212159
Pubmed	The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers.	ATXN2L NR2C1 RBMS2 MATR3 HNRNPM EIF2S3B CHD7 ZNF318 PRPF8 PABPC1 PRPF40A CREM ARID1B TOX4 EIF2S3 PABPC3 ELAVL1 PDS5A	6.79e-08	954	141	18	36373674
Pubmed	Systematic analysis of the protein interaction network for the human transcription machinery reveals the identity of the 7SK capping enzyme.	CDC42EP4 DSG1 MATR3 INTS1 HNRNPM PRPF8 PABPC1 CCNT2 TELO2 ELAVL1 TTI1 CNOT1	7.26e-08	390	141	12	17643375
Pubmed	Interactome of vertebrate GAF/ThPOK reveals its diverse functions in gene regulation and DNA repair.	ATF7 ATXN2L DSG1 ADRM1 MYO10 RBMS2 MATR3 EIF2S3B ZEB2 EIF2S3 ANKRD17	8.84e-08	321	141	11	32098917
Pubmed	Proximity-dependent biotin identification (BioID) reveals a dynamic LSD1-CoREST interactome during embryonic stem cell differentiation.	NCOA3 NR2C1 CRTC1 CHD7 ZNF318 ZEB2 TOX4 CYB5R3 ANKRD17 IRS2 CRYBG3 CNOT1	1.53e-07	418	141	12	34709266
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: III. the complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	SEMA6C MATR3 CRTC1 AGAP11 SIK3 KMT2C ARID1B TELO2 ANKIB1 ANKRD17 DEPDC5 ESPL1 CNOT1	2.71e-07	529	141	13	14621295
Pubmed	TRIM33 drives prostate tumor growth by stabilizing androgen receptor from Skp2-mediated degradation.	NCOA3 MATR3 HNRNPM PRPF8 PRPF40A KMT2C ARID1B ELAVL1 PDS5A	3.13e-07	220	141	9	35785414
Pubmed	Human transcription factor protein interaction networks.	NCOA3 NR2C1 ADRM1 FOS MATR3 CHD7 ZNF318 SSBP3 PABPC1 PRPF40A ZEB2 KMT2C ARID1B PABPC3 CYB5R3 ANKRD17 ELAVL1 PDS5A DOT1L SSBP4 CNOT1	3.35e-07	1429	141	21	35140242
Pubmed	TNF-α inhibits glucocorticoid receptor-induced gene expression by reshaping the GR nuclear cofactor profile.	TANC2 NCOA3 AMPD1 MUC16 CHD7 SIK3 REV3L ITPR3 CRYL1 ARID1B ANKRD17 IRS2 WDFY3 CNOT1	3.62e-07	638	141	14	31182584
Pubmed	New roles for the de-ubiquitylating enzyme OTUD4 in an RNA-protein network and RNA granules.	ATXN2L MATR3 INTS1 HNRNPM PABPC1 PACS1 PABPC3 ASPM ANKRD17 ELAVL1 CNOT1 TOP3B	4.45e-07	462	141	12	31138677
Pubmed	Rearrangement of the Protein Phosphatase 1 Interactome During Heart Failure Progression.	ATF7 NCOA3 HNRNPM PRPF8 PABPC1 TOX4 ELAVL1 IRS2	6.01e-07	174	141	8	29669786
Pubmed	TRIM24 is an insulin-responsive regulator of P-bodies.	DSG1 MATR3 HNRNPM ANKRD17 ELAVL1 CNOT1	9.37e-07	80	141	6	35803934
Pubmed	PRP19 transforms into a sensor of RPA-ssDNA after DNA damage and drives ATR activation via a ubiquitin-mediated circuitry.	MATR3 INTS1 HNRNPM PRPF8 PABPC1 PRPF40A CELF1 ELAVL1 PDS5A ALPP	1.39e-06	340	141	10	24332808
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	TANC2 NCOA3 ITSN1 MATR3 HNRNPM CHD7 ZNF318 SIK3 PABPC1 ZEB2 PABPC3 ANKRD17 ELAVL1 WDFY3 CNOT1 TOP3B	2.01e-06	963	141	16	28671696
Pubmed	Characterization of an exchangeable gene trap using pU-17 carrying a stop codon-beta geo cassette.	TFEB CDC42EP4 MYO10 ZNF205 CHD7 AGAP11 MED13L VPS13D CELF1 TTI1 WDFY3 KLHL8	2.09e-06	536	141	12	15840001
Pubmed	Exchangeable gene trap using the Cre/mutated lox system.	TFEB CDC42EP4 MYO10 ZNF205 CHD7 AGAP11 MED13L VPS13D CELF1 TTI1 WDFY3 KLHL8	2.17e-06	538	141	12	10512203
Pubmed	Integrative genomics positions MKRN1 as a novel ribonucleoprotein within the embryonic stem cell gene regulatory network.	ATXN2L MATR3 PABPC1 PABPC3 ELAVL1	2.27e-06	52	141	5	26265008
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	TANC2 TFEB ATXN2L CDC42EP4 MATR3 CRTC1 SIK3 PABPC1 ZCCHC14 VPS13D ANKRD17 IRS2 CRYBG3 RNF180 ABTB2	2.42e-06	861	141	15	36931259
Pubmed	Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.	TANC2 HNRNPM ZNF318 SIK3 REV3L TUBGCP5 PRPF40A ARID1B PNPLA6 ZNRF3 TELO2 ASPM ANKRD17 IRS2 WDFY3 CRYBG3 BAHCC1	3.03e-06	1116	141	17	31753913
Pubmed	A genome-wide short hairpin RNA screening of jurkat T-cells for human proteins contributing to productive HIV-1 replication.	KIAA0408 NCOA3 MAGEA9 AFF2 ZNF205 ZCCHC14 PABPC3 ANKRD17	3.25e-06	218	141	8	19460752
Pubmed	Assembly, verification, and initial annotation of the NIA mouse 7.4K cDNA clone set.	BRME1 WDFY4 CREM GK PIEZO2 BTG2 TELO2	3.80e-06	157	141	7	12466305
Pubmed	A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning.	TANC2 TFEB NCOA3 MYO10 RBMS2 HNRNPM CRTC1 PLEKHA6 PABPC1 TELO2 BTBD7 EIF2S3 IRS2 ESPL1 CNOT1 ABTB2	5.21e-06	1038	141	16	26673895
Pubmed	H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids.	TFEB ATF7 FOS MATR3 INTS1 HNRNPM ZNF205 CHD7 ZNF318 PRPF8 PRPF40A CREM ITPR3 KMT2C TOX4 CELF1 ELAVL1 PDS5A	5.35e-06	1294	141	18	30804502
Pubmed	The protein interaction landscape of the human CMGC kinase group.	TFEB CDC42EP4 DSG1 FOS RBMS2 HNRNPM MED13L PRPF8 PABPC1 PRPF40A CCNT2 EIF2S3 MED27	5.52e-06	695	141	13	23602568
Pubmed	Resolution of cell fate decisions revealed by single-cell gene expression analysis from zygote to blastocyst.	TFEB ATF7 NCOA3 NR2C1 FOS ZNF205 ZNF318 EBF1 CREM ZCCHC14 TOX4 BTBD7 PLAG1 ABTB2	5.68e-06	808	141	14	20412781
Pubmed	A genome-wide screen to identify transcription factors expressed in pelvic Ganglia of the lower urinary tract.	NR2C1 HIC1 FOS ZNF318 EBF1 CREM ZCCHC14 KMT2C TOX4 PLAG1 RNF180 RNF139 ABTB2	6.83e-06	709	141	13	22988430
Pubmed	Systematic mapping of genetic interactions for de novo fatty acid synthesis identifies C12orf49 as a regulator of lipid metabolism.	ATXN2L ADRM1 MYO10 MATR3 TMEM126B INTS1 MED13L TUBGCP5 CREM CCNT2 KMT2C BTBD7 ASPM ANKRD17 ELAVL1 DEPDC5 RNF139 CNOT1	7.55e-06	1327	141	18	32694731
Pubmed	Granzyme B proteolyzes receptors important to proliferation and survival, tipping the balance toward apoptosis.	ITSN1 PABPC1 PABPC3	7.67e-06	10	141	3	16798735
Pubmed	NFX1-123 and poly(A) binding proteins synergistically augment activation of telomerase in human papillomavirus type 16 E6-expressing cells.	MATR3 HNRNPM PABPC1 PABPC3	8.52e-06	32	141	4	17267499
Pubmed	Construction of long-transcript enriched cDNA libraries from submicrogram amounts of total RNAs by a universal PCR amplification method.	ITSN1 MATR3 CRTC1 CHD7 ZNF318 WDFY4 STAT6 PACS1 KMT2C TAOK3 ARID1B CELF1 ANKRD17 DOT1L ESPL1 CNOT1	8.95e-06	1084	141	16	11544199
Pubmed	The TIP60 Complex Is a Conserved Coactivator of HIF1A.	MATR3 HNRNPM PRPF8 PNPLA6 TELO2 ELAVL1	9.97e-06	120	141	6	27320910
Pubmed	SND1 binds SARS-CoV-2 negative-sense RNA and promotes viral RNA synthesis through NSP9.	ATXN2L RBMS2 MATR3 HNRNPM PABPC1 PRPF40A ELAVL1 TOP3B	1.11e-05	258	141	8	37794589
Pubmed	The SARS-CoV-2 RNA interactome.	MATR3 HNRNPM PABPC1 CELF1 ELAVL1	1.31e-05	74	141	5	33989516
Pubmed	A comprehensive resource of interacting protein regions for refining human transcription factor networks.	KIAA0408 ATF7 FOS MATR3 TAOK3 STOML1 ANKIB1	1.37e-05	191	141	7	20195357
Pubmed	Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.	ATXN2L INTS1 CHD7 ZNF318 PRPF8 PABPC1 PRPF40A ITPR3 ANKRD17 ELAVL1 PDS5A CNOT1	1.53e-05	653	141	12	22586326
Pubmed	BTG2 bridges PABPC1 RNA-binding domains and CAF1 deadenylase to control cell proliferation.	PABPC1 BTG2	1.63e-05	2	141	2	26912148
Pubmed	Effects of SCR-3 on the immunosuppression accompanied with the systemic inflammatory response syndrome.	NCOA3 RBMS2	1.63e-05	2	141	2	22198336
Pubmed	Early B Cell Factor Activity Controls Developmental and Adaptive Thermogenic Gene Programming in Adipocytes.	EBF1 EBF2	1.63e-05	2	141	2	32130892
Pubmed	The promoter of the Poly(A) binding protein 2 (Pabp2) retroposon is derived from the 5'-untranslated region of the Pabp1 progenitor gene.	PABPC1 PABPC3	1.63e-05	2	141	2	10534404
Pubmed	A novel intronic cAMP response element modulator (CREM) promoter is regulated by activator protein-1 (AP-1) and accounts for altered activation-induced CREM expression in T cells from patients with systemic lupus erythematosus.	FOS CREM	1.63e-05	2	141	2	21757709
Pubmed	Nucleotide sequence of a mouse testis poly(A) binding protein cDNA.	PABPC1 PABPC3	1.63e-05	2	141	2	1630930
Pubmed	Critical role for Ebf1 and Ebf2 in the adipogenic transcriptional cascade.	EBF1 EBF2	1.63e-05	2	141	2	17060461
Pubmed	Developmental expression of poly(A) binding protein mRNAs during spermatogenesis in the mouse.	PABPC1 PABPC3	1.63e-05	2	141	2	7893484
Pubmed	Characterization of two cytoplasmic poly(A)-binding proteins, PABPC1 and PABPC2, in mouse spermatogenic cells.	PABPC1 PABPC3	1.63e-05	2	141	2	19020299
Pubmed	Reconstitution of HuR-Inhibited CUGBP1 Expression Protects Cardiomyocytes from Acute Myocardial Infarction-Induced Injury.	CELF1 ELAVL1	1.63e-05	2	141	2	28350193
Pubmed	Functional compensation for the loss of testis-specific poly(A)-binding protein, PABPC2, during mouse spermatogenesis.	PABPC1 PABPC3	1.63e-05	2	141	2	26971890
Pubmed	Levels of free PABP are limited by newly polyadenylated mRNA in early Spisula embryogenesis.	PABPC1 PABPC3	1.63e-05	2	141	2	10954604
Pubmed	The mouse gene encoding the testis-specific isoform of Poly(A) binding protein (Pabp2) is an expressed retroposon: intimations that gene expression in spermatogenic cells facilitates the creation of new genes.	PABPC1 PABPC3	1.63e-05	2	141	2	9732454
Pubmed	MUC16 promotes triple-negative breast cancer lung metastasis by modulating RNA-binding protein ELAVL1/HUR.	MUC16 ELAVL1	1.63e-05	2	141	2	36918912
Pubmed	Structural Model of the Human BTG2-PABPC1 Complex by Combining Mutagenesis, NMR Chemical Shift Perturbation Data and Molecular Docking.	PABPC1 BTG2	1.63e-05	2	141	2	35640718
Pubmed	Sexually dimorphic expression of the X-linked gene Eif2s3x mRNA but not protein in mouse brain.	EIF2S3B EIF2S3	1.63e-05	2	141	2	16325480
Pubmed	Dynamic protein-protein interaction wiring of the human spliceosome.	MATR3 HNRNPM PRPF8 PABPC1 PRPF40A CELF1 ELAVL1	1.67e-05	197	141	7	22365833
Pubmed	Large-scale characterization of HeLa cell nuclear phosphoproteins.	ATXN2L NCOA3 ITSN1 MATR3 CHD7 ZNF318 PRPF40A CCNT2 PACS1 PNPLA6 ANKRD17 IRS2 ESPL1	1.72e-05	774	141	13	15302935
Pubmed	O-GlcNAcylated LARP1 positively regulated by circCLNS1A facilitates hepatoblastoma progression through DKK4/β-catenin signalling.	PABPC1 BTG2 CNOT1	1.81e-05	13	141	3	37070251
Pubmed	Comparative Application of BioID and TurboID for Protein-Proximity Biotinylation.	NCOA3 RBMS2 MATR3 HNRNPM PRPF40A KMT2C ARID1B PNPLA6 ANKRD17 CNOT1	1.86e-05	457	141	10	32344865
Pubmed	Reactive-site-centric chemoproteomics identifies a distinct class of deubiquitinase enzymes.	DSG1 MATR3 HNRNPM PRPF8 ASPM	2.43e-05	84	141	5	29563501
Pubmed	N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective.	ATXN2L NR2C1 DSG1 MATR3 HNRNPM ZNF318 PRPF8 PABPC1 PRPF40A TOX4 EIF2S3 CYB5R3 ANKRD17 IRS2	2.84e-05	934	141	14	33916271
Pubmed	A human MAP kinase interactome.	CDC42EP4 FOS ITSN1 HNRNPM CRTC1 PLEKHA6 SIK3 KMT2C TOX4 ANKRD17	3.13e-05	486	141	10	20936779
Pubmed	Global analysis of TDP-43 interacting proteins reveals strong association with RNA splicing and translation machinery.	ATXN2L MATR3 HNRNPM PABPC1 CELF1 EIF2S3 ELAVL1	3.70e-05	223	141	7	20020773
Pubmed	In silico APC/C substrate discovery reveals cell cycle-dependent degradation of UHRF1 and other chromatin regulators.	ATXN2L NCOA3 ADRM1 MYO10 MATR3 HNRNPM PRPF8 PABPC1 EIF2S3 QPRT ASPM ANKRD17 ELAVL1 PDS5A	4.33e-05	971	141	14	33306668
Pubmed	BAG5 Promotes Alpha-Synuclein Oligomer Formation and Functionally Interacts With the Autophagy Adaptor Protein p62.	HNRNPM ZNF318 PRPF8 PABPC1 CRYBG3 CNOT1	4.40e-05	156	141	6	32850835
Pubmed	Genetic and Proteomic Interrogation of Lower Confidence Candidate Genes Reveals Signaling Networks in β-Catenin-Active Cancers.	ATXN2L MATR3 HNRNPM PLEKHA6 MED13L PRPF8 PABPC1 PRPF40A ITPR3 CCNT2 CRYL1 EIF2S3 ANKRD17 ELAVL1 DOT1L MED27	4.88e-05	1247	141	16	27684187
Pubmed	An interplay between the p38 MAPK pathway and AUBPs regulates c-fos mRNA stability during mitogenic stimulation.	FOS ELAVL1	4.88e-05	3	141	2	25588078
Pubmed	Embryonic Poly(A)-Binding Protein Is Required During Early Stages of Mouse Oocyte Development for Chromatin Organization, Transcriptional Silencing, and Meiotic Competence.	PABPC1 PABPC3	4.88e-05	3	141	2	26134869
Pubmed	Human testis expresses a specific poly(A)-binding protein.	PABPC1 PABPC3	4.88e-05	3	141	2	11328870
Pubmed	The transcriptional co-activator p/CIP (NCoA-3) is up-regulated by STAT6 and serves as a positive regulator of transcriptional activation by STAT6.	NCOA3 STAT6	4.88e-05	3	141	2	15145939
Pubmed	Superovulation alters embryonic poly(A)-binding protein (Epab) and poly(A)-binding protein, cytoplasmic 1 (Pabpc1) gene expression in mouse oocytes and early embryos.	PABPC1 PABPC3	4.88e-05	3	141	2	25034140
Pubmed	The characterization of the Olf-1/EBF-like HLH transcription factor family: implications in olfactory gene regulation and neuronal development.	EBF1 EBF2	4.88e-05	3	141	2	9151732
Pubmed	SIRT1 Functions as a Negative Regulator of Eukaryotic Poly(A)RNA Transport.	PABPC1 PABPC3	4.88e-05	3	141	2	28756945
Pubmed	The poly(A)-binding protein genes, EPAB, PABPC1, and PABPC3 are differentially expressed in infertile men with non-obstructive azoospermia.	PABPC1 PABPC3	4.88e-05	3	141	2	26843391
Pubmed	Piezo2 expressing nociceptors mediate mechanical sensitization in experimental osteoarthritis.	PIEZO2 SCN10A	4.88e-05	3	141	2	37120427
Pubmed	Nuclear relocalisation of cytoplasmic poly(A)-binding proteins PABP1 and PABP4 in response to UV irradiation reveals mRNA-dependent export of metazoan PABPs.	PABPC1 PABPC3	4.88e-05	3	141	2	21940797
Pubmed	The mouse Y-box protein, MSY2, is associated with a kinase on non-polysomal mouse testicular mRNAs.	PABPC1 PABPC3	4.88e-05	3	141	2	10076007
Pubmed	Competitive binding of CUGBP1 and HuR to occludin mRNA controls its translation and modulates epithelial barrier function.	CELF1 ELAVL1	4.88e-05	3	141	2	23155001
Pubmed	Epab and Pabpc1 are differentially expressed during male germ cell development.	PABPC1 PABPC3	4.88e-05	3	141	2	22814100
Pubmed	DOT1L activity affects neural stem cell division mode and reduces differentiation and ASNS expression.	BTG2 DOT1L	4.88e-05	3	141	2	37382163
Pubmed	Long noncoding RNA uc.230/CUG-binding protein 1 axis sustains intestinal epithelial homeostasis and response to tissue injury.	CELF1 ELAVL1	4.88e-05	3	141	2	36214222
Pubmed	De novo variants in the PABP domain of PABPC1 lead to developmental delay.	PABPC1 PABPC3	4.88e-05	3	141	2	35511136
Pubmed	Age-Progressive and Gender-Dependent Bone Phenotype in Mice Lacking Both Ebf1 and Ebf2 in Prrx1-Expressing Mesenchymal Cells.	EBF1 EBF2	4.88e-05	3	141	2	35137272
Pubmed	Epab is dispensable for mouse spermatogenesis and male fertility.	PABPC1 PABPC3	4.88e-05	3	141	2	24599567
Pubmed	Known turnover and translation regulatory RNA-binding proteins interact with the 3' UTR of SECIS-binding protein 2.	CELF1 ELAVL1	4.88e-05	3	141	2	19106619
Pubmed	The RNA-binding proteins CELF1 and ELAVL1 cooperatively control the alternative splicing of CD44.	CELF1 ELAVL1	4.88e-05	3	141	2	35973378
Pubmed	Differential 3' Processing of Specific Transcripts Expands Regulatory and Protein Diversity Across Neuronal Cell Types.	PABPC1 PABPC3	4.88e-05	3	141	2	29578408
Pubmed	A novel, evolutionarily conserved gene family with putative sequence-specific single-stranded DNA-binding activity.	SSBP3 SSBP4	4.88e-05	3	141	2	12079286
Pubmed	Domain-functional analyses of PIWIL1 and PABPC1 indicate their synergistic roles in protein translation via 3'-UTRs of meiotic mRNAs.	PABPC1 PABPC3	4.88e-05	3	141	2	29701755
Pubmed	CUGBP1 and HuR regulate E-cadherin translation by altering recruitment of E-cadherin mRNA to processing bodies and modulate epithelial barrier function.	CELF1 ELAVL1	4.88e-05	3	141	2	26491048
Pubmed	Translation repression via modulation of the cytoplasmic poly(A)-binding protein in the inflammatory response.	PABPC1 PABPC3	4.88e-05	3	141	2	28635594
Pubmed	Disruptor of telomeric silencing 1-like (DOT1L) is involved in breast cancer metastasis via transcriptional regulation of MALAT1 and ZEB2.	ZEB2 DOT1L	4.88e-05	3	141	2	31952940
Pubmed	Epab and Pabpc1 are differentially expressed in the postnatal mouse ovaries.	PABPC1 PABPC3	4.88e-05	3	141	2	25370180
Pubmed	Cytoplasmic poly(A)-binding protein 1 (PABPC1) interacts with the RNA-binding protein hnRNPLL and thereby regulates immunoglobulin secretion in plasma cells.	PABPC1 PABPC3	4.88e-05	3	141	2	28611064
Pubmed	A twin UGUA motif directs the balance between gene isoforms through CFIm and the mTORC1 signaling pathway.	PABPC1 PABPC3	4.88e-05	3	141	2	37665675
Pubmed	Jnk2 deletion disrupts intestinal mucosal homeostasis and maturation by differentially modulating RNA-binding proteins HuR and CUGBP1.	CELF1 ELAVL1	4.88e-05	3	141	2	24740539
Pubmed	E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins.	ITSN1 INTS1 HNRNPM BRME1 REV3L PRPF8 DSCAML1 FOCAD KMT2C PDS5A CNOT1 ZNF582	4.89e-05	736	141	12	29676528
Pubmed	Insights into specificity, redundancy and new cellular functions of C/EBPa and C/EBPb transcription factors through interactome network analysis.	MYO10 MATR3 PABPC1 PACS1 PABPC3	5.37e-05	99	141	5	27746211
Pubmed	Ablation of the oncogenic transcription factor ERG by deubiquitinase inhibition in prostate cancer.	MATR3 PRPF8 PRPF40A ELAVL1	6.02e-05	52	141	4	24591637
Interaction	TOP3B interactions	TANC2 DOCK3 SEMA6C TFEB MYO10 INTS1 HNRNPM REV3L MED13L PABPC1 ITPR3 FOCAD ZCCHC14 KMT2C KLHL25 PNPLA6 CELF1 ZNRF3 ADAMTS7 BTBD7 ANKRD17 ELAVL1 DEPDC5 IRS2 POFUT1 WDFY3 DOT1L SSBP4 ESPL1 CNOT1 TOP3B ABTB2 BAHCC1	8.48e-10	1470	138	33	int:TOP3B
Interaction	TBXT interactions	NCOA3 NR2C1 CHD7 SSBP3 ZEB2 KMT2C ARID1B DOT1L	1.35e-06	116	138	8	int:TBXT
Interaction	SOX7 interactions	NCOA3 CHD7 ZEB2 KMT2C ARID1B DOT1L BAHCC1	1.50e-06	82	138	7	int:SOX7
Interaction	SMG7 interactions	NCOA3 ZNF318 PABPC1 CRYL1 ARID1B CELF1 ANKRD17 ELAVL1 DOT1L CNOT1 TOP3B ABTB2	2.07e-06	319	138	12	int:SMG7
Interaction	PUM1 interactions	ATXN2L NTRK1 RBMS2 MATR3 PABPC1 CELF1 ANKRD17 ELAVL1 DOT1L CNOT1 TOP3B	4.69e-06	287	138	11	int:PUM1
Interaction	PABPC1 interactions	ATXN2L ADRM1 NTRK1 RBMS2 MATR3 PRPF8 WDFY4 PABPC1 KMT2C BTG2 CELF1 EIF2S3 PABPC3 ELAVL1 DOT1L CNOT1 TOP3B	6.02e-06	699	138	17	int:PABPC1
Interaction	NFIB interactions	NCOA3 NR2C1 FOS SSBP3 KMT2C ARID1B ELAVL1 DOT1L	6.12e-06	142	138	8	int:NFIB
Interaction	UBAP2L interactions	DOCK3 ATXN2L NTRK1 RBMS2 PABPC1 ZCCHC14 CELF1 ANKRD17 ELAVL1 CNOT1 TOP3B	6.70e-06	298	138	11	int:UBAP2L
Interaction	FAM76A interactions	ATXN2L PRPF40A TOX4 ELAVL1	1.15e-05	21	138	4	int:FAM76A
Interaction	CEBPA interactions	ATF7 ATXN2L NCOA3 NR2C1 FOS MATR3 HNRNPM CHD7 ZNF318 MED13L PABPC1 ZEB2 CCNT2 KMT2C TAOK3 ARID1B TEX30 CELF1 EIF2S3 ELAVL1 PDS5A MED27 CNOT1	1.23e-05	1245	138	23	int:CEBPA
Interaction	TRIM33 interactions	NCOA3 MAGEA9 FOS NTRK1 MATR3 HNRNPM SSBP3 PRPF8 PABPC1 ARID1B QPRT ELAVL1 SSBP4	1.45e-05	453	138	13	int:TRIM33
Interaction	TRIM24 interactions	MAGEA9 DSG1 FOS NTRK1 MATR3 HNRNPM STAT6 QPRT ANKRD17 ELAVL1 CNOT1 ABTB2	1.94e-05	398	138	12	int:TRIM24
Interaction	JUN interactions	ATF7 ATXN2L NCOA3 FOS HNRNPM IP6K1 STAT6 PACS1 KMT2C ELAVL1 PDS5A CES4A TOP3B	2.14e-05	470	138	13	int:JUN
Interaction	PAX7 interactions	NCOA3 NR2C1 CHD7 SSBP3 KMT2C ARID1B SSBP4	2.34e-05	124	138	7	int:PAX7
Interaction	ERG interactions	NCOA3 MATR3 HNRNPM CHD7 PRPF8 PRPF40A KMT2C ARID1B ELAVL1	2.36e-05	223	138	9	int:ERG
Interaction	IRF4 interactions	NCOA3 CHD7 SSBP3 STAT6 KMT2C ARID1B	2.59e-05	85	138	6	int:IRF4
Interaction	PATL1 interactions	NTRK1 ITSN1 CELF1 QPRT ANKRD17 ELAVL1 CNOT1 TOP3B	3.04e-05	177	138	8	int:PATL1
Interaction	ALG13 interactions	NCOA3 RBMS2 PABPC1 PRPF40A EGFL6 ARID1B CELF1 WDFY3	3.85e-05	183	138	8	int:ALG13
Interaction	FUBP3 interactions	NTRK1 RBMS2 MATR3 PABPC1 CELF1 ANKRD17 ELAVL1 DOT1L CNOT1 TOP3B	3.90e-05	297	138	10	int:FUBP3
Interaction	LHX3 interactions	NR2C1 CHD7 SSBP3 ZEB2 KMT2C ARID1B INSC SSBP4	4.16e-05	185	138	8	int:LHX3
Interaction	ZBTB7B interactions	ATF7 ATXN2L ADRM1 MYO10 RBMS2 MATR3 HNRNPM PRPF8 ZEB2 EIF2S3 ANKRD17	4.49e-05	366	138	11	int:ZBTB7B
Interaction	GAREM2 interactions	NTRK1 ITSN1 TOP3B	4.98e-05	11	138	3	int:GAREM2
Interaction	YTHDF3 interactions	NTRK1 RBMS2 PABPC1 ZCCHC14 CELF1 ANKRD17 DOT1L CNOT1 TOP3B	5.08e-05	246	138	9	int:YTHDF3
Interaction	CNOT7 interactions	MAGEA9 PABPC1 BTG2 ANKRD17 ELAVL1 CNOT1 TOP3B	5.10e-05	140	138	7	int:CNOT7
Interaction	SMC5 interactions	ATXN2L NR2C1 RBMS2 MATR3 HNRNPM EIF2S3B CHD7 ZNF318 REV3L PRPF8 PABPC1 PRPF40A CREM ARID1B TOX4 EIF2S3 PABPC3 ELAVL1 PDS5A	5.26e-05	1000	138	19	int:SMC5
Interaction	PSPC1 interactions	ATXN2L NR2C1 NTRK1 HNRNPM PABPC1 PRPF40A FOCAD TOX4 CELF1 EIF2S3 ANKRD17 ELAVL1 DOT1L	5.49e-05	515	138	13	int:PSPC1
Interaction	DAZL interactions	ATXN2L RBMS2 PABPC1 CELF1 ANKRD17 CNOT1 TOP3B	6.38e-05	145	138	7	int:DAZL
Interaction	PRKD2 interactions	ATXN2L MYO10 NTRK1 AGAP11 PRPF40A ADAMTS7 ELAVL1 DOT1L TOP3B	6.50e-05	254	138	9	int:PRKD2
Interaction	GATA2 interactions	NCOA3 CHD7 SSBP3 ZEB2 KMT2C ARID1B ELAVL1 TOP3B	6.96e-05	199	138	8	int:GATA2
Interaction	PAIP2 interactions	RBMS2 PABPC1 ELAVL1 CNOT1 TOP3B	7.15e-05	63	138	5	int:PAIP2
Interaction	LHX1 interactions	CHD7 SSBP3 PABPC1 KMT2C ARID1B SSBP4	7.67e-05	103	138	6	int:LHX1
Interaction	LSM14A interactions	ATXN2L NTRK1 PABPC1 CELF1 ANKRD17 ELAVL1 DOT1L CNOT1 TOP3B	7.77e-05	260	138	9	int:LSM14A
Interaction	FMR1 interactions	ATXN2L NCOA3 NTRK1 MATR3 CHD7 SIK3 PABPC1 ANKRD17 ELAVL1 WDFY3 DOT1L CNOT1 TOP3B	8.22e-05	536	138	13	int:FMR1
Interaction	TRIM66 interactions	ZNF318 SIK3 TUBGCP5 TELO2 ASPM IRS2 WDFY3 CRYBG3	8.57e-05	205	138	8	int:TRIM66
Interaction	PPP1CA interactions	TANC2 ATF7 NCOA3 NTRK1 MATR3 HNRNPM PRPF8 WDFY4 PABPC1 PACS1 TOX4 ASPM PPP1R37 ELAVL1 IRS2	8.70e-05	696	138	15	int:PPP1CA
Interaction	RBMS1 interactions	ATXN2L RBMS2 PABPC1 CELF1 ANKRD17 ELAVL1 CNOT1 TOP3B	9.17e-05	207	138	8	int:RBMS1
Interaction	RBM45 interactions	TANC2 RBMS2 MATR3 HNRNPM PABPC1 ELAVL1 KLHL8 DOT1L	9.17e-05	207	138	8	int:RBM45
Interaction	FOCAD interactions	KIAA0408 NCOA3 NTRK1 FOCAD TOP3B	9.62e-05	67	138	5	int:FOCAD
Interaction	NFIC interactions	NCOA3 NR2C1 FOS ZEB2 ZCCHC14 ARID1B ELAVL1 DOT1L	1.01e-04	210	138	8	int:NFIC
Interaction	PAX8 interactions	NCOA3 CHD7 SSBP3 ZEB2 KMT2C ARID1B	1.16e-04	111	138	6	int:PAX8
Interaction	NANOG interactions	ATXN2L INTS1 HNRNPM MUC16 CHD7 SSBP3 PABPC1 ITPR3 KMT2C ARID1B DOT1L CNOT1	1.20e-04	481	138	12	int:NANOG
Interaction	NUFIP2 interactions	ATXN2L RBMS2 PABPC1 PRPF40A CCNT2 TOX4 EIF2S3 ELAVL1 CNOT1 TOP3B ALPP	1.43e-04	417	138	11	int:NUFIP2
Interaction	PPIL4 interactions	ATXN2L NTRK1 PRPF40A CCNT2 TOX4 CELF1 ELAVL1	1.43e-04	165	138	7	int:PPIL4
Interaction	MEX3B interactions	ATXN2L RBMS2 PRPF8 PABPC1 ZCCHC14 ANKRD17 CNOT1 TOP3B	1.49e-04	222	138	8	int:MEX3B
Interaction	AR interactions	NCOA3 NR2C1 MATR3 HNRNPM CHD7 ZNF318 MED13L PRPF8 PABPC1 PRPF40A KMT2C ARID1B TELO2 ELAVL1 PDS5A TNS4 DOT1L MED27	1.50e-04	992	138	18	int:AR
Interaction	CNOT8 interactions	MAGEA9 BTG2 ANKRD17 ELAVL1 CNOT1	1.54e-04	74	138	5	int:CNOT8
Interaction	ADAR interactions	NTRK1 MATR3 INTS1 HNRNPM ZNF318 CELF1 ELAVL1 PDS5A DOT1L	1.60e-04	286	138	9	int:ADAR
Interaction	SMARCC2 interactions	NCOA3 FOS NTRK1 ITSN1 CHD7 SSBP3 PRPF40A ARID1B ELAVL1 DOT1L	1.63e-04	353	138	10	int:SMARCC2
Interaction	RUVBL1 interactions	ADRM1 NTRK1 ITSN1 MATR3 CRTAC1 SSBP3 PRPF8 PABPC1 TELO2 PABPC3 ELAVL1 TTI1 DOT1L	1.65e-04	575	138	13	int:RUVBL1
Interaction	RBM6 interactions	KIAA0408 MATR3 PRPF8 CELF1 ELAVL1 PDS5A	1.70e-04	119	138	6	int:RBM6
Interaction	UBAP2 interactions	NTRK1 PABPC1 CREM CELF1 ANKRD17 DOT1L TOP3B	1.72e-04	170	138	7	int:UBAP2
Interaction	EGR2 interactions	NCOA3 NR2C1 CHD7 ZEB2 KMT2C ARID1B BAHCC1	1.79e-04	171	138	7	int:EGR2
Interaction	POU5F1 interactions	TFEB MATR3 HNRNPM MUC16 CHD7 EBF1 ITPR3 ARID1B TOX4 ANKRD17 ELAVL1 TTI1 CNOT1	1.92e-04	584	138	13	int:POU5F1
Interaction	TLX1 interactions	NCOA3 NR2C1 CHD7 SSBP3 ZEB2 KMT2C ARID1B	2.06e-04	175	138	7	int:TLX1
Interaction	MTA2 interactions	NR2C1 ADRM1 NTRK1 HNRNPM CHD7 PABPC1 ZEB2 PABPC3 ELAVL1 DOT1L TOP3B	2.06e-04	435	138	11	int:MTA2
Interaction	TEAD1 interactions	NR2C1 FOS CHD7 SSBP3 ZEB2 KMT2C ARID1B	2.13e-04	176	138	7	int:TEAD1
Interaction	MED12 interactions	NTRK1 MATR3 HNRNPM MED13L PRPF8 MED27 TOP3B	2.13e-04	176	138	7	int:MED12
Interaction	PDCD1 interactions	ABHD18 TMEM126B GK PNPLA6 WDFY3	2.23e-04	80	138	5	int:PDCD1
Interaction	TIMM22 interactions	ELAVL1 CNOT1 TOP3B	2.38e-04	18	138	3	int:TIMM22
Interaction	CNOT1 interactions	MAGEA9 MYO10 NTRK1 SIK3 PABPC1 BTG2 ANKRD17 CNOT1 TOP3B	2.58e-04	305	138	9	int:CNOT1
Interaction	CDK9 interactions	ATXN2L MYO10 MATR3 INTS1 HNRNPM PABPC1 PRPF40A CCNT2 TOX4 EIF2S3 ELAVL1 DOT1L ESPL1 TOP3B	2.61e-04	685	138	14	int:CDK9
Interaction	R3HDM2 interactions	RBMS2 PABPC1 CELF1 ELAVL1 CNOT1 TOP3B	2.64e-04	129	138	6	int:R3HDM2
Interaction	LHX2 interactions	NR2C1 CHD7 SSBP3 ZEB2 KMT2C ARID1B SSBP4	2.71e-04	183	138	7	int:LHX2
Interaction	MIR7-2 interactions	ATXN2L RBMS2 MATR3 HNRNPM CELF1	2.80e-04	84	138	5	int:MIR7-2
Interaction	MEX3C interactions	ATXN2L PRPF8 PABPC1 ELAVL1 CNOT1	2.80e-04	84	138	5	int:MEX3C
Interaction	RAVER2 interactions	CELF1 QPRT ELAVL1	2.81e-04	19	138	3	int:RAVER2
Interaction	SFN interactions	KIAA0408 TANC2 ATXN2L LNX2 NTRK1 MATR3 HNRNPM SIK3 PRPF8 PABPC1 ANKRD17 IRS2 TNS4 CRYBG3	2.89e-04	692	138	14	int:SFN
Interaction	PAX2 interactions	NCOA3 CHD7 KMT2C ARID1B TOP3B	2.96e-04	85	138	5	int:PAX2
Interaction	YTHDF2 interactions	ATXN2L NTRK1 RBMS2 PABPC1 CELF1 ANKRD17 ELAVL1 CNOT1 TOP3B	3.05e-04	312	138	9	int:YTHDF2
Interaction	BCL9 interactions	FOS SSBP3 ELAVL1 SSBP4 TOP3B	3.13e-04	86	138	5	int:BCL9
Interaction	MEX3A interactions	MYO10 NTRK1 ITSN1 EML6 PRPF8 PABPC1 TOX4 CELF1 PLAG1 CNOT1	3.19e-04	384	138	10	int:MEX3A
Interaction	MKRN2 interactions	SEMA6C RBMS2 CHD7 PABPC1 DSCAML1 CELF1 PLAG1 IRS2 CNOT1 TOP3B	3.26e-04	385	138	10	int:MKRN2
Interaction	LHX9 interactions	SSBP3 ANKRD17 SSBP4	3.29e-04	20	138	3	int:LHX9
Interaction	TOB2 interactions	PABPC1 ELAVL1 CNOT1	3.29e-04	20	138	3	int:TOB2
Interaction	GSC interactions	NCOA3 ZEB2 KMT2C ARID1B BAHCC1	3.30e-04	87	138	5	int:GSC
Interaction	PRRC2A interactions	NTRK1 RBMS2 HNRNPM PABPC1 CELF1 EIF2S3 ANKRD17 DOT1L CNOT1 TOP3B	3.54e-04	389	138	10	int:PRRC2A
Interaction	NR3C1 interactions	TANC2 DOCK3 NCOA3 AMPD1 MUC16 CHD7 SIK3 REV3L ITPR3 CRYL1 ARID1B ANKRD17 ELAVL1 IRS2 TNS4 WDFY3 CNOT1	3.63e-04	974	138	17	int:NR3C1
Interaction	TNRC6C interactions	ITSN1 PABPC1 CELF1 ANKRD17 CNOT1 TOP3B	3.79e-04	138	138	6	int:TNRC6C
Interaction	PROKR1 interactions	INTS1 TELO2 TTI1	3.82e-04	21	138	3	int:PROKR1
Interaction	HELZ interactions	RBMS2 PABPC1 CELF1 ANKRD17 ELAVL1 CNOT1 TOP3B ABTB2	4.00e-04	257	138	8	int:HELZ
Interaction	MCRIP2 interactions	ATXN2L PABPC1 CELF1 TOP3B	4.10e-04	51	138	4	int:MCRIP2
Interaction	CARM1 interactions	TFEB NCOA3 ADRM1 FOS NTRK1 PABPC1 ELAVL1 DEPDC5 DOT1L	4.10e-04	325	138	9	int:CARM1
Interaction	PAPOLA interactions	ATXN2L NTRK1 PABPC1 PABPC3 ELAVL1	4.27e-04	92	138	5	int:PAPOLA
Interaction	HNRNPD interactions	NCOA3 FOS NTRK1 MATR3 HNRNPM PLEKHA6 PRPF8 PABPC1 CELF1 ELAVL1 DEPDC5 DOT1L ESPL1	4.48e-04	638	138	13	int:HNRNPD
Interaction	MIR205 interactions	ATXN2L RBMS2 MATR3 HNRNPM CELF1	4.49e-04	93	138	5	int:MIR205
Interaction	CNOT6L interactions	MAGEA9 BTG2 ANKRD17 CNOT1 TOP3B	4.49e-04	93	138	5	int:CNOT6L
Interaction	RBX1 interactions	MATR3 HNRNPM IP6K1 PABPC1 ZEB2 ARID1B KLHL13 ELAVL1 DEPDC5 KLHL8 CNOT1 ABTB2	4.64e-04	558	138	12	int:RBX1
Interaction	GIGYF2 interactions	TANC2 ATXN2L NTRK1 PRPF8 PABPC1 ANKRD17 ELAVL1 DOT1L	4.66e-04	263	138	8	int:GIGYF2
Interaction	PUM2 interactions	NTRK1 RBMS2 PABPC1 CELF1 ANKRD17 ELAVL1	4.75e-04	144	138	6	int:PUM2
Interaction	SNRPA interactions	NTRK1 MATR3 HNRNPM ZNF318 PRPF8 PABPC1 PRPF40A TOX4 ELAVL1 KLHL8 TOP3B	4.92e-04	482	138	11	int:SNRPA
Interaction	TNFRSF21 interactions	MATR3 ELAVL1 TOP3B	5.03e-04	23	138	3	int:TNFRSF21
Interaction	FEV interactions	NCOA3 NR2C1 CHD7 SSBP3 ZEB2 KMT2C ARID1B	5.05e-04	203	138	7	int:FEV
Interaction	SRSF11 interactions	LNX2 ADRM1 NTRK1 PRPF40A TOX4 CELF1 DOT1L	5.05e-04	203	138	7	int:SRSF11
Interaction	SUPT5H interactions	NTRK1 INTS1 CHD7 SSBP3 PRPF8 ZEB2 CCNT2 ARID1B TOX4 DOT1L	5.13e-04	408	138	10	int:SUPT5H
Interaction	FPR1 interactions	INTS1 IP6K1 TELO2 TTI1 PDS5A WDFY3	5.30e-04	147	138	6	int:FPR1
Interaction	SOX9 interactions	NCOA3 CHD7 KMT2C ARID1B KLHL13	5.45e-04	97	138	5	int:SOX9
Interaction	DDX39B interactions	DSG1 NTRK1 MATR3 HNRNPM PRPF8 PABPC1 PRPF40A CRYL1 EIF2S3 ELAVL1 TOP3B ALPP	5.60e-04	570	138	12	int:DDX39B
Interaction	TCERG1 interactions	NTRK1 HNRNPM PRPF8 PRPF40A CELF1 ELAVL1 DOT1L	5.68e-04	207	138	7	int:TCERG1
Interaction	RBBP4 interactions	NR2C1 HIC1 DSG1 ADRM1 MYO10 NTRK1 ITSN1 CHD7 ZEB2 ELAVL1 DOT1L BAHCC1	5.87e-04	573	138	12	int:RBBP4
Interaction	CNOT6 interactions	MAGEA9 PABPC1 ELAVL1 CNOT1	5.87e-04	56	138	4	int:CNOT6
GeneFamily	Basic leucine zipper proteins\|BTB domain containing	HIC1 KLHL25 BTBD7 KLHL13 KLHL8 ABTB2	5.89e-05	134	91	6	861
GeneFamily	TTT complex	TELO2 TTI1	7.49e-05	3	91	2	1320
GeneFamily	RNA binding motif containing	RBMS2 HNRNPM PABPC1 CELF1 PABPC3 ELAVL1	7.23e-04	213	91	6	725
GeneFamily	WD repeat domain containing\|BEACH domain containing	WDFY4 WDFY3	8.82e-04	9	91	2	1230
GeneFamily	Kelch like\|BTB domain containing	KLHL25 KLHL13 KLHL8	1.23e-03	42	91	3	617
GeneFamily	Basic leucine zipper proteins	ATF7 FOS CREM	1.92e-03	49	91	3	506
GeneFamily	Pleckstrin homology domain containing\|Rho guanine nucleotide exchange factors\|C2 domain containing	PSD2 MYO10 ITSN1 PLEKHA6 IRS2	3.85e-03	206	91	5	682
Coexpression	PUJANA_ATM_PCC_NETWORK	MAGEA9 NR2C1 AFF2 RBMS2 MATR3 INTS1 HNRNPM BRME1 PCDHA12 ZNF318 PABPC1 PRPF40A ZCCHC14 CCNT2 TAOK3 CELF1 TELO2 EIF2S3 ELAVL1 PDS5A DEPDC5 RNF139 ESPL1 SLC14A2 CNOT1	7.89e-08	1394	139	25	M9585
Coexpression	BOYLAN_MULTIPLE_MYELOMA_C_D_UP	ITSN1 EBF1 PABPC1 ZEB2 EGFL6 PABPC3 PDS5A POFUT1	9.94e-07	143	139	8	MM788
Coexpression	MANNO_MIDBRAIN_NEUROTYPES_HGABA	TANC2 DOCK3 PSD2 AFF2 ZNF318 EBF1 PLEKHA6 SIK3 REV3L MED13L SSBP3 DSCAML1 EBF2 PACS1 TAOK3 PIEZO2 CELF1 KLHL13 ANKIB1	6.34e-06	1106	139	19	M39071
Coexpression	LAKE_ADULT_KIDNEY_C16_COLLECTING_SYSTEM_PRINCIPAL_CELLS_CORTEX	TANC2 MYO10 SIK3 REV3L MED13L ARID1B ABTB2	1.06e-05	141	139	7	M39235
Coexpression	BOYLAN_MULTIPLE_MYELOMA_C_D_UP	ITSN1 EBF1 PABPC1 ZEB2 EGFL6 PDS5A POFUT1	1.16e-05	143	139	7	M16927
Coexpression	LAKE_ADULT_KIDNEY_C17_COLLECTING_SYSTEM_PCS_STRESSED_DISSOC_SUBSET	TANC2 MYO10 FOS SIK3 MED13L ARID1B BTG2 ABTB2	4.42e-05	240	139	8	M39236
Coexpression	BENPORATH_EED_TARGETS	HIC1 PSD2 AFF2 FOS NTRK1 HNRNPM CRTAC1 EBF1 SLC30A3 DSCAML1 ZEB2 EGFL6 SORCS1 ZCCHC14 BTG2 ELAVL1 ABTB2	4.75e-05	1059	139	17	M7617
ToppCell	nucseq\|World / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	TANC2 MATR3 PLEKHA6 SIK3 MED13L ZEB2 KMT2C ARID1B ANKRD17	1.10e-08	193	140	9	779276e775cb2492e8dd36436295a536084a6415
ToppCell	PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_immature4_(1)\|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung	MYO10 FOS SIK3 TAOK3 PIEZO2 BTG2 KLHL25	2.66e-06	193	140	7	cf3cbf79ccd34ddcf06ec6194a18a7afd7f91f39
ToppCell	Tracheal-NucSeq\|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations	SIK3 MED13L FOCAD PACS1 KMT2C ARID1B WDFY3	3.26e-06	199	140	7	94b94b17ca18b8dc27b91da1f2ccf89e03cc7035
ToppCell	Dendritic_Cells-Donor_04\|World / lung cells shred on cell class, cell subclass, sample id	FOS PABPC1 SPTBN5 KLHL13 TTI1	7.29e-06	85	140	5	d2776a2c8d1721dbbd7d5dc868a3810e30dd9064
ToppCell	Control-B_naive-1\|World / disease group and sub_cluster of B and Plasma cells(res = 0.5)	MATR3 EIF2S3B ZNF318 WDFY4 PABPC1 PABPC3	9.73e-06	155	140	6	0a78d1cab2bdba2dc8a74cdf35b5a0192370c4b5
ToppCell	mild-Myeloid-Eosinophils\|mild / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs	NTRK1 SPATA31A6 PNPLA6 KLHL13 DEPDC5 ABTB2	1.30e-05	163	140	6	7c57d541a88e9afa079e95b8a6ecdea60a0c6aaa
ToppCell	mild-Myeloid-Eosinophils\|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs	NTRK1 SPATA31A6 TEX30 PNPLA6 DEPDC5 ABTB2	1.70e-05	171	140	6	5c8198182495bda7a826e9d80aa467f4eb1094ec
ToppCell	Severe-B_naive-8\|Severe / disease group and sub_cluster of B and Plasma cells(res = 0.5)	DSG1 FOS EBF1 ZEB2 IRS2 BAHCC1	1.88e-05	174	140	6	f3f8c924420f46321bd47e2b97f18c7241541599
ToppCell	E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-PMP\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	PSD2 CRTAC1 SHC2 ADAMTS7 ASPM ESPL1	1.94e-05	175	140	6	a154b28b0b2180652d51d4c7d804b3b81b35899e
ToppCell	E16.5-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1-AT1_prolif\|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	TANC2 TOX4 KLHL25 PNPLA6 TOP3B DCBLD2	2.34e-05	181	140	6	f6629fa71bb94405f523f63a9264cacf6d15c5f4
ToppCell	TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-4\|TCGA-Pancreas / Sample_Type by Project: Shred V9	REV3L MED13L ZEB2 EBF2 CRYBG3 KLHL8	2.57e-05	184	140	6	67164bb6bcae7322cb89b585c7aa10bce35b0ecd
ToppCell	facs-Mammary_Gland-Mammary_Gland-21m\|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ATXN2L FOS SSBP3 PABPC1 IRS2 SLC41A1	2.73e-05	186	140	6	bd1185592aedebccd1007dbf2dd2f549fcdf9f42
ToppCell	Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_monocytic-classical_monocyte\|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	MUC16 MED13L ZEB2 KMT2C SCN10A IRS2	2.73e-05	186	140	6	23b8d51d20b05795a73892d3e20e0f9b6a207820
ToppCell	(2)_Fibroblasts-(20)_Fibro-1\|(2)_Fibroblasts / Cell class and subclass of bone marrow stroma cells in homeostatis	HIC1 EBF1 ZEB2 CFB EBF2 KLHL13	2.73e-05	186	140	6	e93415b59dd89bc8a966dab0e0b65fe215933598
ToppCell	pdx-Tumor_cells-T5\|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells)	SSBP3 SORCS1 ZNRF3 TNS4 WDFY3 ABTB2	2.81e-05	187	140	6	7e376831a11ee72ed87abcdac631ca46ae29c250
ToppCell	facs-Mammary_Gland-Mammary_Gland-21m-Epithelial\|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ATXN2L FOS SSBP3 PABPC1 IRS2 SLC41A1	2.99e-05	189	140	6	965e0e388251e7318f8b463816dc96ccb4658677
ToppCell	renal_medulla_nuclei\|World / Celltypes from Cells and Nuclei per compartment and clinical group	MYO10 EML6 SIK3 ARID1B ANKRD17 WDFY3	2.99e-05	189	140	6	830d9cd0dd706bce22eb2416f07b2c31c870a05a
ToppCell	nucseq-Mesenchymal-Myocytic-Myocytic_1-Pericyte\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	AFF2 MYO10 EBF1 EGFL6 EBF2 INSC	3.08e-05	190	140	6	4eb92aef1ee868f4537483d19014d947b7684612
ToppCell	nucseq-Mesenchymal-Myocytic-Myocytic_1\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	AFF2 MYO10 EBF1 EGFL6 EBF2 INSC	3.08e-05	190	140	6	7be4341e2909101d756f14031c21e705eb45e69a
ToppCell	LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	KIAA0408 DOCK3 EBF1 ZEB2 EGFL6 KLHL13	3.26e-05	192	140	6	992d08092edbc68c47b945deb8708379738c239a
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	TANC2 MYO10 EML6 CRTAC1 BTG2 ABTB2	3.26e-05	192	140	6	fd08ae787e936cfdb1ab8f19b0fd63005b462709
ToppCell	PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature4_(1)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	FOS SIK3 CREM TAOK3 BTG2 KLHL25	3.26e-05	192	140	6	6bba80887d6f64cf913a5c22f62baaddda417ce0
ToppCell	PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature4_(1)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	CDC42EP4 FOS TAOK3 BTG2 KLHL25 ABTB2	3.26e-05	192	140	6	3f925a80b5e2b0577d573e88598a2984a5f6a789
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Cortical_Collecting_Duct_Principal_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	MYO10 FOS EML6 CRTAC1 BTG2 ABTB2	3.26e-05	192	140	6	bae236c9f1fac77bce28d0a9cf090100d391ff77
ToppCell	droplet-Marrow-nan-3m-Myeloid-granulocytopoietic_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MATR3 EBF1 EGFL6 ADAMTS7 ASPM PDS5A	3.46e-05	194	140	6	8ef0b71fef5b84cfd04973f891215333e7035d1d
ToppCell	RA-02._Fibroblast_II\|RA / Chamber and Cluster_Paper	EBF1 REV3L SORCS1 EBF2 ARID1B ABTB2	3.56e-05	195	140	6	6a02ebbeb3199447ddce64d92d8809436e040eba
ToppCell	390C-Lymphocytic-NK_cells-NK_cell_A\|NK_cells / Donor, Lineage, Cell class and subclass (all cells)	HIC1 FOS PABPC1 CREM ZEB2 BTG2	3.87e-05	198	140	6	a1c8e5c332336823c47c04e56b6d7bc8f057c9da
ToppCell	mild-B_memory\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	NCOA3 MAGEA9 EML6 CHD7 EBF1 WDFY4	3.98e-05	199	140	6	e6ac9a0959b0de2c6a99298feb7715aa80ade1dd
ToppCell	LPS_anti-TNF-Mesenchymal_myocytic-Myofibroblastic\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	KIAA0408 DOCK3 ITSN1 ZEB2 QPRT KLHL13	3.98e-05	199	140	6	e9820d5fb4e8b46973c4c50ac5db8fb4a1bf603b
ToppCell	(09)_Interm._secr.>cil.-(2)_GFP_FOXI1\|(09)_Interm._secr.>cil. / shred by cell type by condition	TANC2 ITSN1 MATR3 REV3L PRPF40A ANKIB1	3.98e-05	199	140	6	fc680f85ebd3bab4c72876a19a461b0afb5f51ce
ToppCell	LPS_IL1RA-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	KIAA0408 ITSN1 ZEB2 INSC QPRT KLHL13	3.98e-05	199	140	6	6b3a0e5d52a30d0eed30e6a670f5b53bc233f70c
ToppCell	LPS_IL1RA_TNF-Mesenchymal_myocytic\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	KIAA0408 DOCK3 AFF2 ZEB2 EGFL6 KLHL13	4.10e-05	200	140	6	f599e4b051ac3dad11ad437e98dc8ea6754cca53
ToppCell	LPS_IL1RA-Mesenchymal_myocytic-Myofibroblastic\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	KIAA0408 DOCK3 ITSN1 ZEB2 QPRT KLHL13	4.10e-05	200	140	6	87827041663013f5e7273168dc8709d69840e7ce
ToppCell	mild-B_intermediate\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	NCOA3 EML6 CHD7 EBF1 WDFY4 ARID1B	4.10e-05	200	140	6	fe815824e9e4be3f3db73610e3814a7fd533da65
ToppCell	LPS_IL1RA-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	KIAA0408 DOCK3 ITSN1 ZEB2 QPRT KLHL13	4.10e-05	200	140	6	8988f113708eef7d9d2a6a6c1bcfd7c8f9804d3e
ToppCell	mild-B_naive\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	NCOA3 CHD7 ZNF318 EBF1 WDFY4 ARID1B	4.10e-05	200	140	6	222789b897e2a683bbfd1d00b6fd8705015d90df
ToppCell	Severe-B_naive-8\|World / disease group and sub_cluster of B and Plasma cells(res = 0.5)	DSG1 FOS ZEB2 IRS2 BAHCC1	9.54e-05	145	140	5	a24cad86509208bc7267b02ef1d1b0a25a2a7043
ToppCell	PBMC-Control-Lymphocyte-B-B_cell-B_intermediate-B_intermediate-1\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	MATR3 EML6 CHD7 EBF1 WDFY4	1.51e-04	160	140	5	7ad065337ac802de52c15ee715f6b78a3eed0cef
ToppCell	Healthy/Control-CD8+_T_naive\|Healthy/Control / Disease group and Cell class	MYO10 PLEKHA6 SHC2 KLHL13 PLAG1	1.51e-04	160	140	5	e1386c21fcbbf57fa32d8bdfba3cb1887477ff73
ToppCell	368C-Myeloid-Dendritic-cDC1\|Myeloid / Donor, Lineage, Cell class and subclass (all cells)	WDFY4 KLHL25 KLHL13 STOML1 ALPP	1.56e-04	161	140	5	1011094c54381d52566e24c92f89f2efc2aa3eea
ToppCell	facs-Marrow-KLS-18m-Lymphocytic-BM_CD4_T_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HIC1 ABHD18 TUBGCP5 PARP10 KLHL8	1.80e-04	166	140	5	aa2df07eff323ded751ced8938af08223d7f2029
ToppCell	P15-Mesenchymal-mesenchymal_fibroblast-mesothelial_cell_of_visceral_pleura\|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	MUC16 CFB INSC SCN10A TNS4	1.80e-04	166	140	5	545f6c91102568791443717e522f89cb3bd1a070
ToppCell	facs-Marrow-KLS-18m-Lymphocytic-CD4-positive,_alpha-beta_T_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HIC1 ABHD18 TUBGCP5 PARP10 KLHL8	1.80e-04	166	140	5	695298a94d62b8adab083900003ec636fbaae5d9
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Connecting_Tubule_Intercalated_Cell_Type_A\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	TFEB DSCAML1 EBF2 DOT1L ABTB2	1.85e-04	167	140	5	edc5f04584b44f99ff9a62bbe0dab6fc044fb334
ToppCell	3'-Adult-LargeIntestine-Epithelial-epithelial_progenitor_cell-Stem_cells\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	FOS BTG2 ZNRF3 ELAVL1 PDS5A	1.90e-04	168	140	5	b08458164d270d625b8ee390122d1c2ce8c653db
ToppCell	PND01-03-samps-Mesenchymal-Pericyte-pericyte_F\|PND01-03-samps / Age Group, Lineage, Cell class and subclass	AMPD1 LNX2 EBF1 STOML1 KLHL8	2.01e-04	170	140	5	71718dcebd48105994c313bb55babc70301170a0
ToppCell	10x_5'_v1-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia/MHC-Z\|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	EML6 SLC30A3 ZCCHC14 ESPL1 ZNF582	2.01e-04	170	140	5	dfef8f79960979335b86b4730f224239b40735d5
ToppCell	severe-Myeloid-Eosinophils\|severe / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs	NTRK1 TEX30 PNPLA6 IRS2 ABTB2	2.01e-04	170	140	5	863f0266d5837cdbc3e09a3fe6a99dd3e6261674
ToppCell	10x_5'_v1-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia/MHC\|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	EML6 SLC30A3 ZCCHC14 ESPL1 ZNF582	2.01e-04	170	140	5	fb6098137d010175978596bc382e9ecba9c3891e
ToppCell	Control-Fibroblasts-Pericytes\|Control / group, cell type (main and fine annotations)	AFF2 EBF1 EGFL6 EBF2 INSC	2.06e-04	171	140	5	080003f698f867935c2bfc55d241d3650f45a0ab
ToppCell	Control-B_naive-1\|Control / disease group and sub_cluster of B and Plasma cells(res = 0.5)	MATR3 EIF2S3B ZNF318 PABPC1 PABPC3	2.06e-04	171	140	5	d18855b24aadea38fd1e4592f945cf15b85e05f1
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	KIAA0408 HIC1 EBF1 ZEB2 PIEZO2	2.12e-04	172	140	5	1ef243bce63d841c25e4b74d029d1377f84bcc3d
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	KIAA0408 HIC1 EBF1 ZEB2 PIEZO2	2.12e-04	172	140	5	ab1c81be29f93ca8920c6ab5ab92f497a9256d3f
ToppCell	390C-Myeloid-Dendritic-cDC_proliferating_1\|Myeloid / Donor, Lineage, Cell class and subclass (all cells)	SEMA6C BRME1 PABPC3 ASPM ESPL1	2.12e-04	172	140	5	6fcc16f1067672967ecbcdfdc727649ae9891dd9
ToppCell	Control-B_cells-Plasma_cells\|Control / group, cell type (main and fine annotations)	NCOA3 AMPD1 AFF2 EML6 BTG2	2.29e-04	175	140	5	fb23858cfce71509cafbe0d9728e678012ff2962
ToppCell	Healthy_Control-Myeloid-Mast\|Healthy_Control / Condition, Lineage, Cell class and cell subclass	PSD2 MYO10 NTRK1 PIEZO2 ADAMTS7	2.29e-04	175	140	5	ca187074adcc9b8bd0fa270e2ede1564c8e6c6cf
ToppCell	Healthy_Control-Myeloid-Mast-\|Healthy_Control / Condition, Lineage, Cell class and cell subclass	PSD2 MYO10 NTRK1 PIEZO2 ADAMTS7	2.29e-04	175	140	5	eadbbcdf2aef4cee268bc70a7a2c4175d898953b
ToppCell	COVID-mDC1-\|COVID / Condition, Cell_class and T cell subcluster	PLEKHA6 WDFY4 DSCAML1 SPTBN5 CRYBG3	2.29e-04	175	140	5	83a95d6fc2ddf3ec53f05825bbc982fb8d2ccd15
ToppCell	COVID-mDC1\|COVID / Condition, Cell_class and T cell subcluster	PLEKHA6 WDFY4 DSCAML1 SPTBN5 CRYBG3	2.29e-04	175	140	5	b9280444016e21c28131a61df65cc5c56d402412
ToppCell	Control-B_cells\|Control / group, cell type (main and fine annotations)	NCOA3 AMPD1 EML6 EBF1 WDFY4	2.36e-04	176	140	5	9125caa27bf790f6b1b960a86c09b4bcb1b58641
ToppCell	3'-Adult-SmallIntestine-Hematopoietic-B_cells-Memory_B\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	MAGEA9 AFF2 EML6 WDFY4 ZEB2	2.42e-04	177	140	5	0d1c39e99144fdb9c7f6f98a1ade41c73db45b65
ToppCell	COVID-19-B_cells-Activated_B_cells\|COVID-19 / group, cell type (main and fine annotations)	TFEB NCOA3 CHD7 EBF1 WDFY4	2.42e-04	177	140	5	653bb62a3744d4024ab3186ee01d410ed62832a6
ToppCell	5'-GW_trimst-2-LargeIntestine-Epithelial-mature_enterocytic-Paneth\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	TMEM61 MATR3 DSCAML1 ZNRF3 SLC14A2	2.42e-04	177	140	5	3743a7d69db9ac4cad70eb531f7075849f34f16b
ToppCell	5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell-Pericytes-Pericytes_L.2.3.3.0\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	AFF2 MYO10 EBF1 EGFL6 INSC	2.55e-04	179	140	5	dc6cd46fa652b296ddbc41855f6377946d0a4cdc
ToppCell	Children_(3_yrs)-Immune-B_cell-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	TFEB NCOA3 EML6 EBF1 WDFY4	2.61e-04	180	140	5	40a12eb852373ae3d7c8d9bca376b0ae99f724b3
ToppCell	RA-01._Fibroblast_I\|World / Chamber and Cluster_Paper	AFF2 NTRK1 EBF1 SORCS1 ABTB2	2.68e-04	181	140	5	2b6ddeb53a79a658e2ba78527ff48c155b20daa6
ToppCell	Children_(3_yrs)-Mesenchymal-pericyte_cell-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	AFF2 MYO10 EBF1 EBF2 SHC2	2.68e-04	181	140	5	451b87ac95154bb80018b8dd245b4a6389d81411
ToppCell	Healthy-multiplets\|World / disease group, cell group and cell class	TANC2 FOS PLEKHA6 WDFY4 QPRT	2.68e-04	181	140	5	f8dbac3cd500cc8d80853312b00d124c27b8fd85
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Cortical_Collecting_Duct_Principal_Cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	EML6 CRTAC1 BTG2 KLHL8 ABTB2	2.68e-04	181	140	5	b7c85fbef3c06d5dc32a2a58f8d3dfabf1d79d9f
ToppCell	nucseq-Immune-Lymphocytic_B-Lymphocytic_B-B\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	NCOA3 EML6 EBF1 WDFY4 PACS1	2.68e-04	181	140	5	8d8cc4dae2c8bd5f4b1c159f2a52edc4c9449c86
ToppCell	normal-na-Lymphocytic_B-B_mem-male\|normal / PBMC cell types (v2) per disease, treatment status, and sex	NCOA3 EML6 CHD7 EBF1 WDFY4	2.75e-04	182	140	5	ee36ea6cb9a5a08aeb83f2b7a249255f0b1a9870
ToppCell	Control-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	KIAA0408 DOCK3 SORCS1 INSC ABTB2	2.82e-04	183	140	5	7eae9b3b4d1c9b135fa7cff348393d4adec474b4
ToppCell	Mild/Remission-B_intermediate-10\|Mild/Remission / disease group and sub_cluster of B and Plasma cells(res = 0.5)	TFEB MATR3 WDFY4 CREM ZEB2	2.82e-04	183	140	5	278064c9f0582463b83bf156d34e77f60187613b
ToppCell	droplet-Marrow-nan-3m\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FOS MATR3 ZEB2 BTG2 PDS5A	2.89e-04	184	140	5	1154a5ad7b8512272b7476f949ddac350910bfb7
ToppCell	LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	KIAA0408 DOCK3 SORCS1 INSC KLHL13	2.96e-04	185	140	5	6712512100ccef456d2e2bd201d0987986c92ac9
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Cortical_Collecting_Duct_Principal_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	MYO10 FOS CREM BTG2 ABTB2	2.96e-04	185	140	5	a0a629e5d2b65f670ea907bd3f5e3caf17687d8f
ToppCell	LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	KIAA0408 DOCK3 SORCS1 INSC KLHL13	2.96e-04	185	140	5	3b2dfc8f4c87be516265dbecfc251276034d0efd
ToppCell	pdx\|World / Sample and Cell Type and Tumor Cluster (all cells)	NCOA3 MYH7B TAOK3 ARID1B ZNRF3	3.04e-04	186	140	5	de8e538c8767d41b8a52f5e58ba1affd4e7244c4
ToppCell	PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c06-NR4A2\|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k)	FOS CREM TOX4 BTG2 IRS2	3.04e-04	186	140	5	ed9b1a784f67e8a297e2a10993a6d97df60581ac
ToppCell	pdx-Tumor_cells\|World / Sample and Cell Type and Tumor Cluster (all cells)	NCOA3 MYH7B TAOK3 ARID1B ZNRF3	3.04e-04	186	140	5	0b88a87158a9ca8de3bf40a4ff1687150707a5f0
ToppCell	Fetal_29-31_weeks-Mesenchymal-pericyte_cell-D150\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	AFF2 FOS EBF1 EGFL6 EBF2	3.11e-04	187	140	5	fa01a61bfd13feb033ba1e35cf513707b1bff8c8
ToppCell	Children_(3_yrs)-Mesenchymal-pericyte_cell-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	CDC42EP4 AFF2 MYO10 EBF1 EBF2	3.11e-04	187	140	5	86250acf088ec0c4800a0dfa031b0d4f7e52c342
ToppCell	10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8\|GI_small-bowel / Manually curated celltypes from each tissue	SIK3 MED13L ZEB2 KMT2C ARID1B	3.19e-04	188	140	5	ab9b725d6e0cdab8e9ddda6dee09e14730e9a578
ToppCell	Children_(3_yrs)-Mesenchymal-pericyte_cell\|Children_(3_yrs) / Lineage, Cell type, age group and donor	AFF2 MYO10 EBF1 EBF2 INSC	3.19e-04	188	140	5	ee151792c7ac9afe820f1a281c6dab383799f358
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Cortical_Collecting_Duct_Principal_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	TANC2 MYO10 EML6 BTG2 ABTB2	3.19e-04	188	140	5	e30a4ddac0da8cdcf621d98e28e3895cd9307e7a
ToppCell	PBMC-Control-Lymphocyte-B-B_cell-B_memory-B_memory-0\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	NCOA3 EML6 CHD7 EBF1 WDFY4	3.19e-04	188	140	5	6f53bcd4caab2fc961af799039ea5c3ddae56781
ToppCell	human_hepatoblastoma-Tumor_cells-T5\|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells)	MYO10 ITSN1 SSBP3 SORCS1 ZNRF3	3.19e-04	188	140	5	b070a0667f1ee9b825b267b6c389b7c42fc436f9
ToppCell	PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_B-B_cell-B_c01-TCL1A\|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k)	FOS ZNF318 EBF1 SIK3 WDFY4	3.27e-04	189	140	5	b13f315f617840eb5143a4e8a33a657c20365c21
ToppCell	LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	KIAA0408 DOCK3 EBF1 EGFL6 KLHL13	3.27e-04	189	140	5	7ab1cfc1657277858339f7258a0c4ae9cb42fdf8
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	EML6 CRTAC1 BTG2 KLHL8 ABTB2	3.27e-04	189	140	5	c9565e962a13a7713056ec3dbb1b67d24f9889c7
ToppCell	renal_cortex_nuclei-Adult_normal_reference\|renal_cortex_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group	MYO10 SORCS1 CRYL1 BTG2 ABTB2	3.27e-04	189	140	5	a48df46274d51e84ffb40264646de7346104efb9
ToppCell	Control-Stromal_mesenchymal-Lung_smooth_muscle\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	KIAA0408 DOCK3 QPRT KLHL13 ABTB2	3.27e-04	189	140	5	45e588b2a4ad9e3ff74e22d9d627ed3571f3b8b8
ToppCell	PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CDC42EP4 AFF2 EBF1 ZEB2 EBF2	3.35e-04	190	140	5	7e4d80a3a7f83b6a50f1d0fe82fb6c242c39d5b0
ToppCell	Fibroblasts-CD55+_Fibroblasts\|Fibroblasts / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues	KIAA0408 EML6 CRTAC1 ITPR3 CRYL1	3.35e-04	190	140	5	b4088128f5acf53f43244c9af9fe44e033f1a57a
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	TANC2 MYO10 EML6 BTG2 ABTB2	3.35e-04	190	140	5	11d3c31167ea71809b4cc3757a0c6ea54a448602
ToppCell	renal_medulla_nuclei-Adult_normal_reference\|renal_medulla_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group	MYO10 FOS BTG2 SLC14A2 ABTB2	3.35e-04	190	140	5	f1363f7806cfc4f14fbc1b0e8dac2de813a88eee
ToppCell	PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_mature\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CDC42EP4 AFF2 EBF1 ZEB2 EBF2	3.35e-04	190	140	5	7fec459cd2ad12c2923a03d098289337c0a4c1d3
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Cortical_Collecting_Duct_Principal_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	TANC2 MYO10 EML6 BTG2 ABTB2	3.35e-04	190	140	5	b7f8c2bb9459f1d7c1690069dd5a25a81a57cc84
ToppCell	Control-Lymphoid_B-B_intermediate\|Control / Disease group, lineage and cell class	NCOA3 EML6 CHD7 EBF1 WDFY4	3.43e-04	191	140	5	0082181dbc39c7c4fd3aa34c3ed61439548e844b
ToppCell	PBMC-Control-Lymphocyte-B-B_cell-B_memory\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	NCOA3 EML6 CHD7 EBF1 WDFY4	3.43e-04	191	140	5	03f6da73e7b706252d2096507222229c4101a27b
Drug	ICI182,780; Down 200; 1uM; PC3; HT_HG-U133A	TANC2 ZNF318 ITPR3 VPS13D TOX4 SHC2 DEPDC5 TOP3B BAHCC1	2.65e-06	196	135	9	7495_DN
Drug	Trichlorfon [52-68-6]; Down 200; 15.6uM; HL60; HT_HG-U133A	TFEB ABHD18 MATR3 SIK3 CCNT2 TOX4 CELF1 POFUT1 BAHCC1	2.88e-06	198	135	9	1839_DN
Drug	Captopril [62571-86-2]; Up 200; 17.2uM; MCF7; HT_HG-U133A	NR2C1 ABHD18 CRTC1 ITPR3 BTBD7 SCN10A DEPDC5 IRS2 POFUT1	3.01e-06	199	135	9	1488_UP
Drug	Dimaprit dihydrochloride [23256-33-9]; Up 200; 17uM; MCF7; HT_HG-U133A	ZNF205 CRTC1 CREM ITPR3 VPS13D BTG2 IRS2 POFUT1 BAHCC1	3.13e-06	200	135	9	7480_UP
Drug	KS24	PABPC1 PABPC3 SAGE1	4.02e-06	6	135	3	CID000099135
Drug	irinotecan HCl; Down 200; 100uM; MCF7; HT_HG-U133A	TANC2 MYO10 ITSN1 CHD7 REV3L MED13L TAOK3 WDFY3	9.62e-06	174	135	8	7530_DN
Drug	Isosorbide dinitrate [87-33-2]; Down 200; 17uM; MCF7; HT_HG-U133A	ATXN2L AFF2 ZNF205 ZCCHC14 VPS13D IRS2 POFUT1 TOP3B	2.20e-05	195	135	8	4742_DN
Drug	Epicatechin-(-) [154-23-4]; Down 200; 13.8uM; PC3; HT_HG-U133A	ATXN2L NR2C1 ZNF205 ZNF318 PACS1 VPS13D BTG2 BAHCC1	2.28e-05	196	135	8	4594_DN
Drug	Trimethylcolchicinic acid [3482-37-9]; Up 200; 11.6uM; MCF7; HT_HG-U133A	NR2C1 AFF2 ZNF205 PACS1 IRS2 POFUT1 WDFY3 BAHCC1	2.36e-05	197	135	8	2802_UP
Drug	Salsolinol hydrobromide [38221-21-5]; Up 200; 15.4uM; MCF7; HT_HG-U133A	TFEB NR2C1 PACS1 KLHL25 BTBD7 IRS2 POFUT1 BAHCC1	2.45e-05	198	135	8	2791_UP
Disease	MARDEN-WALKER SYNDROME	ZEB2 PIEZO2	1.99e-05	2	132	2	C0796033
Disease	MEHMO syndrome (implicated_via_orthology)	EIF2S3B EIF2S3	1.99e-05	2	132	2	DOID:0060801 (implicated_via_orthology)
Disease	autosomal dominant polycystic kidney disease (is_marker_for)	FOS CFB STAT6	3.07e-05	14	132	3	DOID:898 (is_marker_for)
Disease	Neurodevelopmental Disorders	TANC2 MED13L KMT2C ARID1B WDFY3	6.29e-05	93	132	5	C1535926
Disease	autism spectrum disorder (implicated_via_orthology)	CHD7 DSCAML1 ITPR3 TAOK3 ARID1B WDFY3	6.50e-05	152	132	6	DOID:0060041 (implicated_via_orthology)
Disease	mean arterial pressure	EML6 IP6K1 ZNF318 EBF1 EBF2 CCNT2 TAOK3 ZNRF3 PDS5A BAHCC1	8.67e-05	499	132	10	EFO_0006340
Disease	monocyte percentage of leukocytes	SEMA6C ATF7 AFF2 CHD7 EBF1 MED13L EGFL6 EIF2S3 POFUT1 WDFY3 SSBP4 BAHCC1	1.13e-04	731	132	12	EFO_0007989
Disease	Chediak-Higashi syndrome (implicated_via_orthology)	WDFY4 WDFY3	1.18e-04	4	132	2	DOID:2935 (implicated_via_orthology)
Disease	interleukin-10 receptor subunit beta measurement	ITSN1 CFB	1.97e-04	5	132	2	EFO_0020489
Disease	glucose metabolism disease (implicated_via_orthology)	EIF2S3B EIF2S3 IRS2	2.64e-04	28	132	3	DOID:4194 (implicated_via_orthology)
Disease	hypopituitarism (implicated_via_orthology)	EIF2S3B EIF2S3	2.94e-04	6	132	2	DOID:9406 (implicated_via_orthology)
Disease	response to aromatase inhibitor	MUC16 CNOT1 ALPP	3.95e-04	32	132	3	GO_0061477
Disease	growth differentiation factor 15 measurement	CRTC1 WDFY4	4.11e-04	7	132	2	EFO_0009181
Disease	Congenital Pain Insensitivity	NTRK1 SCN10A	4.11e-04	7	132	2	C0002768
Disease	proinsulin measurement	HNRNPM SORCS1	4.11e-04	7	132	2	EFO_0010814
Disease	Hereditary Sensory Autonomic Neuropathy, Type 5	NTRK1 SCN10A	4.11e-04	7	132	2	C0020075
Disease	red blood cell density measurement	ITSN1 CRTC1 SIK3 ZEB2 FOCAD ARID1B KLHL25 ZNRF3 CYB5R3 IRS2 KLHL8 SLC14A2	6.09e-04	880	132	12	EFO_0007978
Disease	hematocrit	RBMS2 CRTC1 EBF1 PLEKHA6 ITPR3 ARID1B ZNRF3 CYB5R3 ANKRD17 IRS2 DOT1L SLC14A2 BAHCC1	6.23e-04	1011	132	13	EFO_0004348
Disease	comparative body size at age 10, self-reported	AMPD1 EBF1 MED13L SSBP3 EBF2 FOCAD BTBD7 SLC41A1	6.25e-04	420	132	8	EFO_0009819
Disease	descending aortic diameter	SIK3 STAT6 ADAMTS7 DOT1L	6.67e-04	88	132	4	EFO_0021788
Disease	leukodystrophy (implicated_via_orthology)	EIF2S3B EIF2S3	7.00e-04	9	132	2	DOID:10579 (implicated_via_orthology)
Disease	lactosyl-N-nervonoyl-sphingosine (d18:1/24:1) measurement	CHD7 CYB5R3	7.00e-04	9	132	2	EFO_0800517
Disease	Carcinoma, Transitional Cell	PABPC1 KMT2C ESPL1	8.24e-04	41	132	3	C0007138
Disease	cancer antigen 125 measurement	MUC16 MSLNL	8.73e-04	10	132	2	EFO_0010603
Disease	C-reactive protein measurement	DOCK3 SEMA6C TFEB ATXN2L RBMS2 CRTAC1 CHD7 EBF1 SLC30A3 PACS1 CELF1 PPP1R37 IRS2 SSBP4	1.04e-03	1206	132	14	EFO_0004458
Disease	autosomal dominant cerebellar ataxia (implicated_via_orthology)	ATXN2L ITPR3	1.27e-03	12	132	2	DOID:1441 (implicated_via_orthology)
Disease	frontal fibrosing alopecia	NR2C1 CDC42EP4 MYO10	1.31e-03	48	132	3	EFO_0009855
Disease	serum albumin measurement	DOCK3 TFEB RBMS2 IP6K1 EBF1 SIK3 PARP10 SSBP4 SLC14A2	1.42e-03	592	132	9	EFO_0004535
Disease	pulse pressure measurement	HIC1 PCDHA12 CRTAC1 ZNF318 EBF1 MED13L CFB EBF2 ARID1B PIEZO2 CELF1 SCN10A DOT1L SLC14A2 CNOT1	1.44e-03	1392	132	15	EFO_0005763
Disease	age at menarche	SEMA6C MYO10 CRTC1 SSBP3 PRPF40A DSCAML1 CELF1 INSC SLC14A2	1.45e-03	594	132	9	EFO_0004703
Disease	Epilepsy	TANC2 FOS ARID1B EIF2S3	1.48e-03	109	132	4	C0014544
Disease	body fat percentage	ATXN2L FOS CRTC1 CRTAC1 IP6K1 EBF1 PACS1 CELF1	1.63e-03	488	132	8	EFO_0007800
Disease	visceral:abdominal adipose tissue ratio measurement	EBF2 ZNRF3 SLC14A2	1.65e-03	52	132	3	EFO_0803318
Disease	T wave morphology measurement	SSBP3 SCN10A	1.74e-03	14	132	2	EFO_0008398
Disease	level of C-X-C motif chemokine 3 in blood serum	SEMA6C TELO2	2.01e-03	15	132	2	OBA_2041208
Disease	Proteinuria	CRYL1 ADAMTS7	2.01e-03	15	132	2	HP_0000093
Disease	P wave duration	SSBP3 SCN10A	2.01e-03	15	132	2	EFO_0005094
Disease	hepcidin:transferrin saturation ratio	EML6 MUC16	2.01e-03	15	132	2	EFO_0007902
Disease	Neuralgia, Supraorbital	NTRK1 SCN10A	2.29e-03	16	132	2	C0038870
Disease	Neuralgia	NTRK1 SCN10A	2.29e-03	16	132	2	C0027796
Disease	Neuralgia, Atypical	NTRK1 SCN10A	2.29e-03	16	132	2	C0234247
Disease	Neuralgia, Stump	NTRK1 SCN10A	2.29e-03	16	132	2	C0234249
Disease	Neuralgia, Iliohypogastric Nerve	NTRK1 SCN10A	2.29e-03	16	132	2	C0423712
Disease	Neuralgia, Perineal	NTRK1 SCN10A	2.29e-03	16	132	2	C0423711
Disease	Paroxysmal Nerve Pain	NTRK1 SCN10A	2.29e-03	16	132	2	C0751373
Disease	Nerve Pain	NTRK1 SCN10A	2.29e-03	16	132	2	C0751372
Disease	Neuralgia, Ilioinguinal	NTRK1 SCN10A	2.29e-03	16	132	2	C0751371
Disease	Neuralgia, Vidian	NTRK1 SCN10A	2.29e-03	16	132	2	C0042656
Disease	monocyte count	ATF7 AFF2 EIF2S3B EBF1 PLEKHA6 MED13L SSBP3 EGFL6 TELO2 PLAG1 CES4A IRS2 SSBP4 SLC41A1	2.41e-03	1320	132	14	EFO_0005091
Disease	proprotein convertase subtilisin/kexin type 7 measurement	SIK3 DSCAML1	2.58e-03	17	132	2	EFO_0008270
Disease	MHPG measurement, 5-HIAA measurement	PIEZO2 KLHL13	2.58e-03	17	132	2	EFO_0005132, EFO_0005133
Disease	acute lymphoblastic leukemia, response to antineoplastic agent	NCOA3 CRTC1	3.23e-03	19	132	2	EFO_0000220, GO_0097327
Disease	Bladder Neoplasm	MAGEA9 PABPC1 KMT2C ESPL1	3.67e-03	140	132	4	C0005695
Disease	Malignant neoplasm of urinary bladder	MAGEA9 PABPC1 KMT2C ESPL1	3.76e-03	141	132	4	C0005684
Disease	Sclerocystic Ovaries	ZNF205 ADAMTS7 ASPM DCBLD2	4.06e-03	144	132	4	C1136382
Disease	Polycystic Ovary Syndrome	ZNF205 ADAMTS7 ASPM DCBLD2	4.06e-03	144	132	4	C0032460

Protein segments in the cluster

Peptide	Gene	Start	Entry
LAPHLMMQSGQLGGD	BAHCC1	796	Q9P281
HTSDNLSMLATGMPS	CCNT2	326	O60583
LSGHMLMPDATCVNS	EGFL6	121	Q8IUX8
MEALHMSANSDIGLG	AGAP11	206	Q8TF27
STAEMKSLHPLQMGG	CRYBG3	2456	Q68DQ2
TLSSLHPMGGLNAMQ	CELF1	246	Q92879
DLDTLMGPLTQHSSM	AFF2	1276	P51816
TGISMGGHMASLAVS	ABHD18	196	Q0P651
QLPALSSSPAHSGMM	EBF2	411	Q9HAK2
LCMGPQIMISEGALH	ANKIB1	86	Q9P2G1
SSAASVGLADMMSPG	ARID1B	1076	Q8NFD5
GLMISLSTDDPMQFH	AMPD1	641	P23109
GSLPLVMHLANGQTM	ATF7	191	P17544
LPHLSSMSPELSMNG	DOT1L	701	Q8TEK3
KLGISPLMLAAMNGH	ANKRD17	1216	O75179
FIGMSSAPRELTGHM	CHD7	461	Q9P2D1
DLGGIPAMINHSDMS	ASPM	1226	Q8IZT6
MNMVAGLFHDPSIGN	ADAMTS7	271	Q9UKP4
PMLQSNPRMLTSGSH	ATXN2L	816	Q8WWM7
MGAQLSTLGHMVLFP	CYB5R3	1	P00387
LDSGMFMNIHPSGVK	NR2C1	236	P13056
GHISMLAPDQFASPM	PDS5A	781	Q29RF7
MMGPLTQQLGHLSLS	RBMS2	336	Q15434
HLMATASAMAGPSSE	H2BW1	21	Q7Z2G1
PMDLDAHISSMLSSG	ITPR3	1541	Q14573
QAMHPTLAGKITGML	PABPC1	571	P11940
LMTDGLHNMGGDPIT	CFB	386	P00751
AMKGLQMTGPISTHS	DEPDC5	1011	O75140
GLSHSEMTNLMSRGP	MUC16	9696	Q8WXI7
MEAPLQTGMMGTSSH	PNPLA6	1	Q8IY17
GLAMSLHFMTLGGSS	NTRK1	461	P04629
SSSMVMRTLNHPLGG	KMT2C	2641	Q8NEZ4
GHTMGDPFMLQQSTN	MATR3	336	P43243
SQDGGMITMHSPKRS	MED13L	351	Q71F56
DSMLGDGHSMPKAAL	MAGEA9	186	P43362
TLLSSPHGGALVMSM	INTS1	1411	Q8N201
LHSGSLGMGPMATEL	FOS	306	P01100
AGQTMLDTMEAPGHS	HIC1	16	Q14526
RMGPLGLDHMASSIE	HNRNPM	456	P52272
GLSTVGMSHSALVPM	LNX2	656	Q8N448
MSSHGALQPAMQALA	FAM90A27P	231	A6NNH2
LHPSATAMMDVSELG	MYH7B	36	A7E2Y1
GNEHLGSMEMFDPLT	KLHL8	376	Q9P2G9
MMSPLASGLFHRAIS	CES4A	231	Q5XG92
DDMASLTELHGGSIM	MYO10	66	Q9HD67
SGGATLSQHLEMLQM	KIAA0408	596	Q6ZU52
IDEVMGHSSESMLPG	TUBGCP5	331	Q96RT8
GPHIDVISMGMLTQA	QPRT	261	Q15274
MDASSIGAADPHMLE	MSLNL	186	Q96KJ4
SPMGVDHMSGLSGVN	ELAVL1	221	Q15717
MSIHLSRPNGTSAML	MED27	176	Q6P2C8
VIQPTSGMIGSLSMH	DSG1	926	Q02413
SGMIGSLSMHPELAN	DSG1	931	Q02413
QAMHPTLAGKITGML	PABPC3	566	Q9H361
LPHSGEAQLSGTMAM	PACS1	861	Q6VY07
QLTHTGMAFLGMTLP	PPP1R37	316	O75864
GMAFLGMTLPHTQSL	PPP1R37	321	O75864
GLMVSEMESHPPSQG	PRPF40A	11	O75400
MQASLDPSVTHLMGL	ALPP	276	P05187
AGGALQHSRSMSMPV	IRS2	421	Q9Y4H2
LEGLSGQELTDHMGM	ESPL1	441	Q14674
QHMKLSLGGSEMGLS	KLHL13	41	Q9P2N7
PSNCLGMMLLSDAHQ	KLHL25	146	Q9H0H3
TASLALAPGSGESMM	BRME1	416	Q0VDD7
LGSMPSTVHIGQSMD	DOCK3	816	Q8IZD9
GMTGTNVMDTHLLFL	GLYCTK	506	Q8IVS8
QAAMMGLTGSHGSLP	CRTC1	531	Q6UUV9
MSDGTTISHMNVTGP	DSCAML1	461	Q8TD84
MSGHLTGPQARTILM	ITSN1	236	Q15811
IMSFHIDLGPSMLGD	CDC42EP4	206	Q9H3Q1
SMPETTALGAAMAAG	GK	456	P32189
LPALANTSVHAGMMG	EBF1	421	Q9UH73
NTAGIDMPMFSALLH	BTBD7	186	Q9P203
INMMALPGGRHLDSV	INSC	46	Q1MX18
LEPFIHQVGGHSSMM	IP6K1	26	Q92551
GMLDLILSHGESMAQ	CRTAC1	416	Q9NQ79
GPLETMHLNAEGMLS	CRYL1	236	Q9Y2S2
SGPMTLLVQGHMEGE	EML6	986	Q6ZMW3
IIMDMSGHPTTSVGQ	DCBLD2	681	Q96PD2
PGHDILMATMLNGAA	EIF2S3B	136	Q2VIR3
TELAPSHMAAATGDM	CREM	236	Q03060
EGTPTMLCLAALHGM	FOCAD	1266	Q5VW36
NAIDKGIPSMAGHSM	PCDHA12	321	Q9UN75
SMPMGSLEHEGLVSL	PARP10	351	Q53GL7
SGVGLLDHMTLNNEM	RNF180	401	Q86T96
MLKDGTAGSHFMASP	POFUT1	251	Q9H488
TLMLMGAVSRSEGAH	MROH5	426	Q6ZUA9
FIHGMTDPVLMSLSA	RNF139	366	Q8WU17
ATGSNDPSMEAHMGA	TAS2R39	246	P59534
HGLPTTSPSGMNMAE	TFEB	326	P19484
MEPHHMNGSLGSGDI	SSBP3	326	Q9BWW4
MAASMHGQPSPSLED	TMEM126B	31	Q8IUX1
QGHLQSMPTGNMRAS	SPATA31A6	1051	Q5VVP1
FHPMTNAATMGLSPE	PRORSD1P	136	A6NEY8
GHLQSMPTGNMRASQ	SPATA31A7	1056	Q8IWB4
PDGMLSMEQVSHGTQ	NCOA3	1011	Q9Y6Q9
PMSSAMIQPHGAASS	SIK3	751	Q9Y2K2
RTPLMMAASEGHLGT	TANC2	1101	Q9HCD6
MDSLGSNHSIPSMSV	TAOK3	341	Q9H2K8
TTPMLQSLLGHLAMD	TELO2	311	Q9Y4R8
ISTFLHMNGMPGENS	SLC41A1	371	Q8IVJ1
SENVHPAGEAGLSMM	SLC36A3	31	Q495N2
PAGEAGLSMMQTLIH	SLC36A3	36	Q495N2
AALASMAHGMAASPA	SPTBN5	1476	Q9NRC6
MAHGMAASPAILEET	SPTBN5	1481	Q9NRC6
ADPLLSMLEAHGMGS	ABTB2	631	Q8N961
MSHGKGTDMLPEIAA	BTG2	1	P78543
GNMSHSQLMQLIGPA	ADRM1	161	Q16186
MMARTHSGLTDGIPL	CNOT1	296	A5YKK6
SGSAHQMITTLPLGM	PLAG1	301	Q6DJT9
GMLSMGHVLIPQSDL	PRPF8	1326	Q6P2Q9
GHLQSMPTGNMRASQ	SPATA31A3	1056	Q5VYP0
MALPQMCDGSHLAST	TMEM61	1	Q8N0U2
MLRVASSSLGMGPQH	TOP3B	306	O95985
SSSLGMGPQHAMQTA	TOP3B	311	O95985
MGTHQELEMFGSQPA	PLEKHA6	566	Q9Y2H5
NGDDDMGTLLGLMHS	WDFY3	601	Q8IZQ1
SSDAVIIHPGAMLAM	WDFY3	841	Q8IZQ1
DMPLMGSAVDHPLSA	REV3L	1266	O60673
CHQSHGPMSLTMGEL	RNASE8	96	Q8TDE3
GHLQSMPAGNMRASQ	SPATA31A1	1056	Q5TZJ5
GHLQSMPTGNMRASQ	SPATA31A5	1056	Q5VU36
HMPSISFASGGDTDM	SHC2	246	P98077
LGHMAAGGIPSMSTK	SAGE1	511	Q9NXZ1
QLALHFLGGSMNSMA	STOML1	241	Q9UBI4
MSQVMSSPLLAGGHA	TNS4	1	Q8IZW8
SRLSLMAMPNGFHED	PSD2	236	Q9BQI7
HHGMSPTFEAMLQIG	SCN10A	686	Q9Y5Y9
QSGISMSHMDLRANP	STAT6	831	P42226
MEPHHVNGSLGSGDM	SSBP4	321	Q9BWG4
EGSLPDLTMMHLTAS	PIEZO2	836	Q9H5I5
VLLSAMELFHMTSGG	WDFY4	1921	Q6ZS81
MAGPHSNITVMFLGS	SEMA6C	431	Q9H3T2
HGASGDMNLPHLMSL	TEX30	36	Q5JUR7
AAHLLADVGSMMGSL	SLC30A3	106	Q99726
MLASNHMNGSNGESP	ZNF582	501	Q96NG8
GSAMMDVLPASAPHQ	ZCCHC14	556	Q8WYQ9
HTTGPKALAMLMLGA	ZNF205	526	O95201
SMDSHGNPVTLLTMD	ZNRF3	386	Q9ULT6
SAQSPMQHLGVGMEA	ZEB2	431	O60315
LVDLTPTHSGSAMLM	SORCS1	1091	Q8WY21
PTHSGSAMLMLLSVV	SORCS1	1096	Q8WY21
PLICLHAAIGSTMGM	SLC14A2	776	Q15849
HAAIGSTMGMLAALT	SLC14A2	781	Q15849
EGTHQALDLLAGGMM	ZNF318	2121	Q5VUA4
VPMTDMTSGLMGHSQ	TOX4	126	O94842
MMEHPGLQAITSGEH	TTI1	586	O43156
HSQGQFTMPLAGMSL	VPS13D	2101	Q5THJ4
PGHDILMATMLNGAA	EIF2S3	136	P41091